Molcan Corporation (Page 2) @ ChemBuyersGuide.com, Inc.

(4S,4aS,5aR,12aS)-4,7-Bis(dimethyl amino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro tetracene-2-carboxamide dihydrochloride ;
CAS:59046-78-5
MNC00X :
Minocycline (2HCl) ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethyl amino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro tetracene-2-carboxamide hydrochloride ;
CAS:13614-98-7
TGC03H :
Tigecycline EP Impurity C (HCl) ; Minocycline HCl ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethyl amino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro tetracene-2-carboxamide hydrochloride ;
CAS:13614-98-7
MNC00H :
Minocycline (HCl) ; Minocycline Hydrochloride ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethyl amino)-9-methylamino-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:607402-73-3
MNC91B :
Minocycline 9-Methylamino Impurity ; 9-Methylamino Minocycline ;

(4S,4aS,5aR,12aS)-4,7-bis(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxamide ;
CAS:149934-16-7
MNC49B :
Minocycline 9-Nitro Impurity (Base) ;

(4S,4aS,5aR,12aS)-4,7-bis(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxamide sulfate salt ;
CAS:153621-80-8
MNC49S :
Minocycline 9-Nitro Impurity (Sulfate) ;

(4S,4aS,5aR,12aS)-4,7-bis(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-N-(hydroxymethyl)-1,11-dioxo-2-naphthacene carboxamide ;
CAS:1075240-33-3
MNC06B :
Minocycline EP Impurity F ; Minocycline N-Hydroxymethyl Impurity ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12a-trihydroxy-12-imino-1,11-dioxo-1,4,4a,5,5a,6,11,11a,12,12a-decahydrotetracene-2-carboxamide ;
CAS:864073-42-7
MNC05B
Minocycline EP Impurity E ; 12-Imino Minocycline ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)-N-nitroso-amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacene carboxamide ;
TGC48 :
Tigecycline N-Nitroso Impurity ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacene carboxamide ;
CAS:220620-09-7
TGC00B :
Tigecycline (Anhydrous) ;

(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacene carboxamide hydrate ;
CAS:1229002-07-6
TGC00X :
Tigecycline (Hydrate) ;

(4S,4aS,5aR,12aS)-4-(Dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:808-26-4
MNC02B :
Minocycline EP Impurity B (Base) ; Sancycline ;

(4S,4aS,5aR,12aS)-4-(Dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:6625-20-3
MNC02H :
Minocycline EP Impurity B (HCl) ; Sancycline HCl ;

(4S,4aS,5aR,12aS)-4-(Dimethylamino)-3,10,12,12a-tetrahydroxy-7-(methylamino)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide ;
CAS:4708-96-7
MNC03B :
Minocycline EP Impurity C (Base) ; 7-Methylamino Sancycline ; 7-Monodemethyl Minocycline ;

(4S,4aS,5aR,12aS)-7-Amino-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:5679-00-5
MNC04B :
Minocycline EP Impurity D (Base) ; 7-Didesmethylamino Minocycline ; 7-Amino Sancycline ;

(4S,4aS,5aR,12aS)-7-Amino-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:95940-02-6
MNC04H :
Minocycline EP Impurity D (HCl) ; 7-Didesmethylamino Minocycline HCl ; 7-Amino Sancycline HCl ;

(4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino) acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,11,12a-hexahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide ;
CAS:1633815-62-9
TGC61B :
Tigecycline Dehydro Impurity ;

(4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide ;
CAS:149934-19-0
TGC02B :
Tigecycline EP Impurity B (Base) ; Tigecycline USP RC B (Base) ; 9-Amino Minocycline ;

(4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride ;
CAS:149934-21-4
TGC02H :
Tigecycline EP Impurity B (HCl) ; Tigecycline USP RC B (HCl) ; 9-Amino Minocycline HCl ;

(4S,4aS,5aR,12aS)-9-Amino-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:5874-95-3
MNC09B :
Minocycline EP Impurity I ;

(4S,4aS,5aS,6S,12aS)-2-Acetyl-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene ;
CAS:6542-44-5 7647-65-6
TCY02B :
Tetracycline EP Impurity B (Base) ; Tetracycline 2-Acetyl Analog ;

(4S,4aS,5aS,6S,12aS)-2-Acetyl-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,11(4H,5H)-dione ;
CAS:6542-44-5 7647-65-6
LMC02 :
Lymecycline EP Impurity B ; 2-Acetyl 2-Decarbamoyl Tetracycline ; Tetracycline 2-Acetyl Analog ; Tetracycline EP Impurity B ;

(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11- dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:60-54-8
OTC02B :
Oxytetracycline EP Impurity B (Base) ; Tetracycline ; Lymecycline EP Impurity H (Base) ;

(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11- dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:64-75-5
OTC02H :
Oxytetracycline EP Impurity B (HCl) ; Tetracycline HCl ; Lymecycline EP Impurity H (HCl) ;

(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:60-54-8
TCY00B :
Tetracycline (Base) ; Oxytetracycline EP Impurity B ; Lymecycline EP Impurity H ;

(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:60-54-8
LMC06B :
Lymecycline EP Impurity H ; Tetracycline ; Oxytetracycline EP Impurity B ;

(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:64-75-5
LMC06H :
Lymecycline EP Impurity H (HCl) ; Tetracycline HCl ; Oxytetracycline EP Impurity B (HCl) ;

(4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride ;
CAS:64-75-5
TCY00H :
Tetracycline (HCl) ; Oxytetracycline EP Impurity B (HCl) ; Lymecycline EP Impurity H (HCl) ;

(4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene carboxamide ;
CAS:57-62-5
TCY52B :
Tetracycline Chloro (Base) ; Lymecycline EP Impurity G ;

(4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene carboxamide hydrochloride ;
CAS:64-72-2
TCY52H :
Tetracycline Chloro HCl ; Lymecycline EP Impurity G ; Chlortetracycline HCl ;

(4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:57-62-5
LMC05B :
Lymecycline EP Impurity G ; Chlortetracycline ;

(4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:64-72-2
LMC05H :
Lymecycline EP Impurity G (HCl) ; Chlortetracycline HCl ;

(4S,5R,6R)-5-Acetamido-4-(tert-butoxycarbonyl)-6-((1R,2R)-1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid ;
CAS:166830-74-6
ZNM53 :
Zanamivir 4-N-t-BOC Amine ;

(4S,5S)-4-benzyl-5-[(2S)-2-[[(2S)-3-methyl-2-[[methyl[[2(1-methylethyl) thiazol-4-yl]methyl]carbamoyl]amino]butanoyl]amino]-3-phenylpropyl] oxazolidin-2-one ;
CAS:256328-82-2
RTN12 :
Ritonavir EP Impurity L ; Oxazolidinone Ritonavir (USP) ; Desthiazolylmethyl Ritonavir ;

(4S,5S,6S)-4-(2,2-Dimethylbutanoyloxy)-5-(2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-6-methyl-3,4,4a,5,6,7-hexahydronaphthalene-2-carboxylic acid ;
CAS:125206-31-7
SVS70
Simvastatin RC 10 ;

(4Z)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid ;
CAS:483-60-3
MCP53 :
Mycophenolic Acid (Z)-Isomer ;

(5+¦,17+¦)-13-Ethyl-17-hydroxy-18,19-dinorpregn-20-yn-3-one ;
CAS:78088-19-4
LNG51 :
Levonorgestrel 5+¦-Dihydro Impurity ; 4,5-Didehydro Levonorgestrel ;

(5-((Methylamino)methyl)furan-2-yl)methanol ;
CAS:66357-60-6
RNT65 :
Ranitidine RC 5 ;

(5-(2,6-Difluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine ;
CAS:928325-41-1
VPZ51B :
Vonoprazan 2,6-Difluoro Impurity (Base) ;

(5-(2,6-Difluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine acetate ;
VPZ51A :
Vonoprazan 2,6-Difluoro Impurity (Acetate Salt) ;

(5-(2-Fluorophenyl)-1-(pyridin-2-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine ;
CAS:928615-46-7
VPZ78B :
Vonoprazan RC 18 ;

(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N,N-dimethylmethanamine ;
CAS:1885094-62-1
VPZ58B :
Vonoprazan N,N-Dimethyl Analog ; N-Methyl Vonoprazan ;

(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-formyl-N-methylmethanamine ;
CAS:3078919-21-5
VPZ53 :
Vonoprazan N-Formyl Impurity ;

(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine ;
CAS:881681-00-1
VPZ00B :
Vonoprazan (Base) ;

(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate ;
CAS:881681-01-2 1260141-27-2
VPZ00F :
Vonoprazan (Fumarate) ; Vonoprazan Fumarate ;

(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanol ;
CAS:2169271-28-5
VPZ84B :
Vonoprazan RC 24 ;

(5-(2-Fluorophenyl)-1-(pyridin-4-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine ;
CAS:2771609-43-7
VPZ77B :
Vonoprazan RC 17 ;

(5-(2-Fluorophenyl)-1H-pyrrol-3-yl)methanol ;
CAS:881674-58-4
VPZ61B :
Vonoprazan RC 1 ;

(5-(3-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine ;
CAS:881733-45-5
VPZ43 :
Vonoprazan 3-Fluoro Isomer ;

(5-(4-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine ;
CAS:881733-36-4
VPZ54B :
Vonoprazan 4-Fluoro Isomer (Base) ;

(5-(4-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine hydrochloride ;
VPZ54H :
Vonoprazan 4-Fluoro Isomer (HCl) ;

(5-[4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl]salicylic acid) ;
CAS:42753-55-9
SSZ31 :
Sulfasalazine USP RC K ; 6-Methyl Sulfasalazine ;

(5-[Acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) ;
CAS:89797-00-2
IDX24 :
Iodixanol USP RC D ; Iopentol ;

(5-Amino-2-methylphenyl)methanol ;
CAS:111437-10-6
RBF63 :
Riboflavin RC 3 ;

(5-Bromothiophen-2-yl)phenylmethanone ;
CAS:31161-46-3
TPF06 :
Tiaprofenic Acid EP Impurity F ;

(5-Chloro-2,1,3-benzothiadiazol-4-yl)cyanamide ;
CAS:51322-80-6
TZN07 :
Tizanidine EP Impurity G ;

(5-Chlorothiophen-2-yl)(3-hydroxyazetidin-1-yl)methanone ;
CAS:1341527-09-0
RVR77 :
Rivaroxaban RC 17 ;

(5-Ethylthiophen-2-yl)phenylmethanone ;
CAS:6933-26-2
TPF01 :
Tiaprofenic Acid EP Impurity A ;

(5-Hydroxy-6-methylpyridine-3,4-diyl)dimethanol ;
CAS:65-23-6
PDX00B :
Pyridoxine (Base) ;

(5-Hydroxy-6-methylpyridine-3,4-diyl)dimethanol hydrochloride ;
CAS:58-56-0
PDX00H :
Pyridoxine (HCl) ;

(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-azidopropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate ;
OLM78 :
Olmesartan RC 18 ; Olmesartan Azide ;

(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2GÇ¦-[(2-triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl] methyl]-1H-imidazole-5-carboxylate ;
CAS:1020157-01-0
OLM04 :
Olmesartan EP Impurity D ; N2-Trityl Olmesartan Medoxomil ; N-Alkyl Olmesartan (USP) ;

(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate ;
CAS:144690-92-6
OLM77 :
Olmesartan RC 17 ; N1-Trityl Olmesartan Medoxomil

(5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-[[2GÇÖ-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1Himidazole-5-carboxylate ;
CAS:879562-26-2
OLM03 :
Olmesartan EP Impurity C ; Anhydro Olmesartan Medoxomil ; Dehydro Olmesartan Medoxomil ; Olmesartan Medoxomil Olefinic Impurity (USP) ; Olmesartan Medoxomil Methylvinyl Impurity ;

(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxybutan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate ;
CAS:1378863-74-1
OLM50 :
Olmesartan Medoxomil Ethyl Analog ;

(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate ;
CAS:144689-63-4
OLM00 :
Olmesartan Medoxomil ;

(5-Nitrofuran-2-yl)methanediol diacetate ; 5-Nitrofuraldehyde Diacetate ;
CAS:92-55-7
NFT65 :
Nifuratel Impurity E ; Nifuroxazide EP Impurity C ; Nitrofurazone EP Impurity B ; Nitrofural EP Impurity B ;

(5-Nitrofuran-2-yl)methylidene diacetate ;
CAS:92-55-7
NFN02 :
Nitrofurazone EP Impurity B ; Nitrofural EP Impurity B ; Nifuroxazide EP Impurity C ; Nifuratel Impurity E ;

(5-Nitrofuran-2-yl)methylidene diacetate ;
CAS:92-55-7
NRX03 :
Nifuroxazide EP Impurity C ; Nitrofurazone EP Impurity B ; Nitrofural EP Impurity B ; Nifuratel Impurity E ;

(5aR,8aR,9R)-9-(3,4,5-Trimethoxyphenyl)-5a,6,8a,9-tetrahydrofuro[3GÇ¦,4GÇ¦:6,7]naphtho[2,3-d][1,3]dioxol-5,8-dione ;
CAS:477-49-6
PPT03 :
Podophyllotoxin EP Impurity C ; Podophyllotoxone ;

(5aS,10aS)-Octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine-5,10-dione ;
CAS:19943-27-2
VDG80 :
Vildagliptin Impurity 10 ;

(5E)-2,2-Dimethyl-7-[(1-naphthalenylmethyl)amino]-5-hepten-3-ynoic acid ;
CAS:99473-15-1
TBN52 :
Terbinafine N-Desmethyl Carboxylic Acid ;

(5E)-2,2-Dimethyl-7-[methyl(1-naphthalenylmethyl)amino]-5-hepten-3-ynoic acid ;
CAS:99473-14-0
TBN50 :
Terbinafine Carboxylic Acid ; Carboxybutyl Terbinafine ;

(5E)-5-[(2-Aminoethoxy)imino]-5-[4-(trifluoromethyl)-phenyl]pentan-1-ol ;
CAS:192876-02-1
FVX07B :
Fluvoxamine EP Impurity G (Base) ; O-Desmethyl Fluvoxamine ;

(5E)-5-[(2-Aminoethoxy)imino]-5-[4-(trifluoromethyl)-phenyl]pentan-1-ol oxalate ;
FVX07X :
Fluvoxamine EP Impurity G (Oxalate) ; O-Desmethyl Fluvoxamine Oxalate ;

(5E,7E)-(24R)-9,10-Secocholesta-5,7,10(19)-triene-1a,3+ƒ,24-triol ;
CAS:1294517-97-7
TCT01 :
Tacalcitol EP Impurity A ; trans-Tacalcitol ;

(5R)-3-((1H-1,2,3-Triazol-1-yl)methyl)-3-methyl-4-thia-1-azabicyclo[3.2.0]heptan-7-one 4,4-dioxide ;
TZB41 :
Tazobactam Descarboxy Impurity ;

(5R)-3-(3-Fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one ;
CAS:856866-72-3
TDZ00 :
Tedizolid ;

(5R)-3-(3-Fluoro-4-(6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one ;
CAS:856866-79-0
TDZ32 :
Tedizolid Impurity 32 ;

(5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazol indinone ;
CAS:168828-82-8
LNZ33 :
Linezolid Hydroxymethyl Impurity ; Linezolid Desacetamide Hydroxy Impurity ;

(5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-[[(methylsulfonyl)oxy]methyl]-2-oxazolidinone ;
CAS:174649-09-3
LNZ24 :
Linezolid USP RC D ; Linezolid Mesylate Impurity ;

(5R)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone ;
CAS:912359-80-9
LNZ44 :
Linezolid N-Desacetyl (R)-Isomer ; Linezolid Impurity D ;

(5R)-5-(Azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone ;
CAS:168828-84-0
LNZ21 :
Linezolid USP RC A ; Linezolid Desacetamide Azide ;

(5R)-5-(Chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one ;
CAS:1239662-46-4
TDZ55 :
Tedizolid Impurity 25 ; Tedizolid 5-Chloromethyl Analog ;

(5R)-5-(Hydroxymethyl)-3-(4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one ;
TDZ56 :
Tedizolid Desfluoro Impurity ;

(5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-5-hydroxy-2-heptenoic acid sodium salt ;
CAS:188067-71-2
LVS39N :
Lovastatin Anhydro Acid Sodium Salt ;

(5R,5aR,8aR)-10-Bromo-5-(3,4,5-trimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one ;
CAS:93108-16-8
PPT57 :
Podophyllotoxin 4-Deoxy 10-Bromo ;

(5R,5aR,8aR)-5,8,8a,9-Tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo [3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:3590-93-0
PPT54 :
Podophyllotoxin p-Desmethyl 9-Desoxy Impurity ;

(5R,5aR,8aR)-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one ;
CAS:19186-35-7
PPT51:
Podophyllotoxin 9-Desoxy Impurity ;

(5R,5aR,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo [3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:518-28-5
PPT00 :
Podophyllotoxin ; Etoposide EP Impurity M ;

(5R,5aR,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:40505-27-9
PPT56 :
Podophyllotoxin p-Desmethyl Impurity ; Etoposide EP Impurity L ;

(5R,5aR,8aR,9R)-9-(+¦-D-Glucopyranosyloxy)-5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxy phenyl)furo[3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:16481-54-2
PPT53 :
Podophyllotoxin 9-O-Glucoside ;

(5R,5aR,8aR,9S)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo [3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:4375-07-09 00:00:00
PPT52 :
Podophyllotoxin 9-Epimer ;

(5R,5aR,8aR,9S)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:6559-91-7
PPT02 :
Podophyllotoxin EP Impurity B ; Podophyllotoxin p-Desmethyl 9-Epimer ;

(5R,5aS,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo [3GÇÖ,4GÇÖ:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:477-47-4
PPT01 :
Podophyllotoxin EP Impurity A ; Podophyllotoxin 5a-Epimer ; Picropodophyllotoxin ;

(5R,5aS,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one ;
CAS:112066-16-7
PPT58 :
Podophyllotoxin 4GÇÖ-Demethyl ;

(5R,6R,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol ;
RMG68 :
Rimegepant RC 8 ;

(5R,6R,9S)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydroimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate ;
RMG69 :
Rimegepant RC 9 ;

(5R,6S)-3-[(2-Aminoethyl)sulfanyl]-6-[(R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0] hept-2-ene-2-carboxylic acid ;
CAS:59995-64-1
IMP01A :
Imipenem EP Impurity A ; Thienamycin ;

(5R,6S)-3-[[2-(Formimidoylamino)ethyl]thio]-6-[(R)-1- hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate ;
CAS:74431-23-5
IMP00A :
Imipenem Monohydrate ;

(5R,6S)-6-Phenyl-5-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,6,7,8-tetrahydronaphthalen-2-ol ;
CAS:180916-16-9
LSF00 :
Lasofoxifene ;

(5R,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol ;
RMG67 :
Rimegepant RC 7 ;

(5R,8R)-8-[[[(1R)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one ;
CAS:1214741-26-0
RLN51 :
Rolapitant (1R,2R,3R)-Isomer ;

(5R,8R)-8-[[[(1S)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one ;
CAS:1214741-30-6
RLN55 :
Rolapitant (1S,2R,3R)-Isomer ;

(5R,8S)-8-[[[(1R)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one ;
CAS:1214741-25-9
RLN52 :
Rolapitant (1R,2R,3S)-Isomer ;

(5R,8S)-8-[[[(1S)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one ;
CAS:1214741-28-2
RLN56 :
Rolapitant (1S,2R,3S)-Isomer ;

(5RS)-3-(2-Hydroxyphenyl)-5-phenylcyclohex-2-enone ;
CAS:15156-56-6
WFR01 :
Warfarin EP Impurity A ; Warfarin USP RC A ;

(5RS)-5-(6-Methoxynaphthalen-2-yl)-3-methylcyclohex-2-enone ;
CAS:343272-51-5
NBM02 :
Nabumetone EP Impurity B ;

(5RS)-5-Ethenylpyrrolidin-2-one ;
CAS:7529-16-0
VGB01 :
Vigabatrin EP Impurity A ; Vigabatrin USP RC A ;

(5RS)-6-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-one ;
CAS:74150-27-9
PMB00 :
Pimobendan ;

(5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one ;
CAS:486-56-6
NTN03 :
Nicotine EP Impurity C ; Nicotine USP RC C ; Cotinine ;

(5S)-3-(3-Fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one ;
CAS:1431699-67-0
TDZ51 :
Tedizolid (S)-Isomer ;

(5S)-5-((1S,2R)-1-Carboxy-2-hydroxypropyl)-3-(2-formamidinoethylthio)-2,5-dihydro-1H-pyrrole-2-carboxylic acid ;
IMP53A :
Imipenem Open-Ring Acid 3-En Isomer ;

(5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone ;
CAS:168828-90-8
LNZ23 :
Linezolid USP RC C ; Linezolid N-Desacetyl Impurity ;

(5S)-9-Fluoro-6,7-dihydro-5-methyl-1-oxo-8-[4-(sulfooxy)-1-piperidinyl]-1H,5H-benzo[ij]quinolizine-2-carboxylic acid ;
CAS:1544562-94-8
NDF53 :
Nadifloxacin (S)-Isomer O-Sulfate ;

(5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-hept-2,6-dienoic acid ethyl ester ;
RSV37 :
Rosuvastatin 2,3-Anhydro Acid Ethyl Ester ; 2,3-Anhydro Rosuvastatin Acid Ethyl Ester ;

(5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-hept-2,6-dienoic acid methyl ester ;
RSV39 :
Rosuvastatin 2,3-Anhydro Acid Methyl Ester ; 2,3-Anhydro Rosuvastatin Acid Methyl Ester ;

(5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydroimidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate ;
CAS:1289023-67-1
RMG00 :
Rimegepant ;

(5S,7R)-N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]-3-hydroxyadamantan-1-amine oxide ;
VDG90 :
Vildagliptin N-Oxide ;

(5S,8R)-8-[[[(1R)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one ;
CAS:552292-73-6
RLN53 :
Rolapitant (1R,2S,3R)-Isomer ;

(5S,8R)-8-[[[(1S)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride ;
CAS:1214741-29-3
RLN57 :
Rolapitant (1S,2S,3R)-Isomer ;

(5S,8R,9R,10S,13S,14S,17S)-17-Ethynyl-13-methyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol ; 19-nor-5+¦,17+¦-pregn-3-en-20-yn-17-ol ;
LNS01 :
Lynestrenol EP Impurity A ; Lynestrenol Delta-3 Isomer ;

(5S,8S)-8-[[[(1R)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride ;
CAS:858102-79-1
RLN00X :
Rolapitant HCl (Anhydrous) ; (R,S,S)-Rolapitant HCl ;

(5S,8S)-8-[[[(1R)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride monohydrate ;
CAS:914462-92-3
RLN00H :
Rolapitant HCl (Monohydrate) ; (R,S,S)-Rolapitant HCl (Monohydrate) ;

(5S,8S)-8-[[[(1S)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one Hydrochloride ;
CAS:1214741-27-1
RLN58 :
Rolapitant (1S,2S,3S)-Isomer ;

(5Z)-5-{[4-({2-[Methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione ;
CAS:160596-25-8
RGT21B :
Rosiglitazone USP RC A ;

(5Z,7E)-(24R)-9,10-Secocholesta-5,7,10(19)-triene-1+ƒ,3+ƒ,24-triol ;
TCT03 :
Tacalcitol EP Impurity C ; 1+ƒ-Tacalcitol ;

(5Z,7E)-(24R)-9,10-Secocholesta-5,7,10(19)-triene-1a,3+ƒ,24-triol ;
CAS:57333-96-7
TCT00A :
Tacalcitol (Anhydrous) ;

(5Z,7E)-(24R)-9,10-Secocholesta-5,7,10(19)-triene-1a,3+ƒ,24-triol monohydrate ;
CAS:93129-94-3
TCT00H :
Tacalcitol Monohydrate ;

(5Z,7E)-(24S)-9,10-Secocholesta-5,7,10(19)-triene-1a,3+ƒ,24-triol
TCT02 :
Tacalcitol EP Impurity B ; (24S)-Tacalcitol ;

(6+¦,11+¦,16+¦)-21-(Acetyloxy)-9-fluoro-6,11-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione ;
CAS:72559-83-2
TCA66 :
Triamcinolone Acetonide RC 6 ;

(6+¦,11+¦,16+¦)-9-Fluoro-6,11,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione ;
CAS:3869-32-7
TCA68 :
Triamcinolone Acetonide RC 8 ; 6+¦-Hydroxy Triamcinolone Acetonide ;

(6+¦,11+¦,16+¦)-9-Fluoro-6,11-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxopregna-1,4-dien-21-oic acid ;
CAS:68263-02-5
TCA67 :
Triamcinolone Acetonide RC 7 ;

(6+¦,11+¦,16+¦,17+¦)-4GÇÖ-Chloro-5GÇÖ-ethyl-6,9-difluoro-11-hydroxy-16-methylspiro[androsta-1,4-diene-17,2GÇÖ(3GÇÖH)-furan]-3,3GÇÖ-dione ;
CAS:912360-04-4
HBS60 :
Halobetasol Spiro Analog ;

(6+¦,9+¦,11+¦)-9,11-Epoxy-17-hydroxy-6-methyl-pregna-1,4-diene-3,20-dione ;
CAS:83873-16-9
FML04 :
Fluorometholone Impurity D ; Fluorometholone 9,11-Epoxy Impurity ;

(6-(tert-Butyldimethylsilyloxy)-2-(4-(tert-butyldimethylsilyloxy)phenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone ;
CAS:182249-24-7
RLX67 :
Raloxifene RC 7 ;

(6-(tert-Butyldimethylsilyloxy)-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone ;
CAS:174264-47-2
RLX66 :
Raloxifene RC 6 ;

(6-Ethoxy-2-(4-ethoxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy) phenyl)methanone ;
RLX59 :
Raloxifene Diethoxy Impurity ;

(6-Ethoxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy) phenyl)methanone ;
RLX55 :
Raloxifene 6-Ethoxy Analog ;

(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-hydroxy phenyl) methanone ;
CAS:177744-96-6
RLX04 :
Raloxifene EP Impurity D ;

(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone ;
CAS:1391054-73-1
RLX02 :
Raloxifene EP Impurity B ; Raloxifene Isomer ;

(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophene-3,7-diyl)bis((4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone ;
CAS:1159977-58-8
RLX01 :
Raloxifene EP Impurity A ; Raloxifene Diketone ;

(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophene-3,7-diyl)bis((4-fluorophenyl)methanone) ;
CAS:1430407-59-2
RLX61 :
Raloxifene RC 1 ;

(6-Hydroxy-2-(4-methoxyphenyl)benzo[b]thiophen-7-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone ;
RLX72 :
Raloxifene RC 12 ;

(6-Methoxynaphthalen-2-yl)acetic acid ;
CAS:23981-47-7
NPX09 :
Naproxen EP Impurity I ; Desmethyl Naproxen ;

(6bR)-12-(1,3-Benzodioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1GÇ¦,2GÇ¦:1,2]-pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione ;
TLF04 :
Tadalafil EP Impurity D ;

(6bR,10aS)-Ethyl 2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate ;
CAS:313544-32-0
LMR62 :
Lumateperone Impurity 2 ;

(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate ;
CAS:313544-76-2
LMR63 :
Lumateperone Impurity 3 ;

(6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-hept-2,4,6-trienoic acid ;
RSV40 :
Rosuvastatin 2,3,4,5-Dianhydro Acid ; Rosuvastatin 2,4,6-Triene Impurity ; 2,3,4,5-Dianhydro Rosuvastatin ;

(6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-hept-2,4,6-trienoic acid methyl ester ;
RSV49 :
Rosuvastatin 2,3,4,5-Dianhydro Acid Methyl Ester ; 2,3,4,5-Dianhydro Rosuvastatin Methyl Ester ;

(6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-hept-2,4,6-trienoic acid ethyl ester ;
RSV47 :
Rosuvastatin 2,3,4,5-Dianhydro Acid Ethyl Ester ; 2,3,4,5-Dianhydro Rosuvastatin Ethyl Ester ;

(6R)-3-Methyl-8-oxo-5,5-dioxide-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester ;
CAS:370588-49-1
TZB69 :
Tazobactam RC 9 ;

(6R)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol ;
CAS:112835-48-0
RTG01B :
Rotigotine EP Impurity A (Base) ; Rotigotine (R)-Isomer ; Ent-Rotigotine ;

(6R)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol HCl ;
RTG01H :
Rotigotine EP Impurity A (HCl) ; Rotigotine (R)-Isomer (HCl) ; Ent-Rotigotine HCl ;

(6R)-5-Hydroxy-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide ;
FTT62 :
Frovatriptan 5-Hydroxy Impurity ; Frovatriptan Impurity 12 ;

(6R)-6-((3S,5R,10S,12S,13R,14R,17R)-3,12-Dihydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid ;
CAS:105742-76-5
GDR53 :
Ganoderic Acid C6 ;

(6R)-6-((5R,10S,12S,13R,14R,17R)-12-Acetoxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid ;
CAS:98665-15-7
GDR56 :
Ganoderic Acid F ;

(6R)-6-[(E)-2-[3-(4-Fuorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one ;
CAS:920275-10-1
FLV05 :
Fluvastatin EP Impurity E ; Fluvastatin BP Impurity E ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2,7-dimethyl-Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:477970-21-1
TLF82 :
Tadalafil Impurity 22 ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-(2-hydroxypropyl)-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:1353020-85-5
TLF80 :
Tadalafil Impurity 20 ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-octylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:1173706-35-8
TLF83 :
Tadalafil Impurity 23 ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydropyrazino [1GÇ¦,2GÇ¦:1,6]-pyrido[3,4-b]indole-1,4-dione ;
CAS:171596-36-4
TLF41 :
Tadalafil N-Desmethyl Impurity ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-butyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:171596-31-9
TLF78 :
Tadalafil Impurity 18 ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-cyclopentyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:171596-32-0
TLF55 :
Tadalafil N-Desmethyl-N-Cyclopentyl ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-ethyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:1609405-34-6
TLF56 :
Tadalafil N-Ethyl ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]-pyrido[3,4-b]indole-1,4-dione ;
CAS:171596-29-5
TLF00 :
Tadalafil ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino [1GÇ¦,2GÇ¦:1,6]-pyrido[3,4-b]indole-1,4-dione ;
CAS:385769-84-6
TLF42B :
Tadalafil N-Desmethyl N-Amino Impurity (Base) ;

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino [1GÇ¦,2GÇ¦:1,6]-pyrido[3,4-b]indole-1,4-dione HCl ;
TLF42H :
Tadalafil N-Desmethyl N-Amino Impurity (HCl) ;

(6R,12aR)-6-(3,4-Dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]-pyrido[3,4-b]indole-1,4-dione ;
CAS:171489-03-5
TLF40 :
Tadalafil Desmethylene Impurity ;

(6R,12aR)-6-(Benzo[d][1,3]dioxol-2-one-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]-pyrido[3,4-b]indole-1,4-dione ;
CAS:1346602-17-2
TLF50 :
Tadalafil Dioxolone Impurity ;

(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
TLF48 :
Tadalafil N-Nitroso Impurity ; N-Nitroso Tadalafil ;

(6R,12aR)-rel-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-(2-hydroxyethyl)-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:385769-94-8
TLF52
Tadalafil 2-Hydroxyethyl ;

(6R,12aR,12bR)-6-(1,3-Benzodioxol-5-yl)-6a-hydroxy-2-methyl-2,3,6a,7,12a,12b-hexahydropyrazino [1GÇ¦,2GÇ¦:1,5]-pyrrolo[3,4-b]quinoline-1,4,12(6H)-trione ;
CAS:2520114-41-2
TLF05 :
Tadalafil EP Impurity E ;

(6R,12aRS,12bR)-6-(1,3-Benzodioxol-5-yl)-6a-hydroxy-2-methyl-2,3,6a,7,12a,12b-hexahydropyrazino [1GÇ¦,2GÇ¦:1,5]-pyrrolo[3,4-b]quinoline-1,4,12(6H)-trione ;
CAS:1978322-99-4
TLF45 :
Tadalafil EP Impurity E (12aRS)-Racemate ;

(6R,12aS)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:929100-66-3
TLF51 :
Tadalafil EP Impurity A N-Desmethyl Impurity ; N-Desmethyl epi-Tadalafil ;

(6R,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:171596-27-3
TLF01 :
Tadalafil EP Impurity A ; Tadalafil (R,S)-Diastereomer (USP) ; Tadalafil (6R,12aS)-Isomer ;

(6R,13S,25R)-5-O-Demethyl-28-deoxy-6,28-epoxy-13-hydroxy-25-[(1S)-1-methylpropyl]milbemycin B ;
CAS:73162-95-5
IVM07 :
Ivermectin EP Impurity G ; Ivermectin B1a Aglycone ;

(6R,14aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,14,14a-tetrahydropyrazino[1,2-d][1,4]benzodiazonine-1,4,7,13(6H,8H)-tetrone ;
CAS:1978322-98-3
TLF08 :
Tadalafil EP Impurity H ; Tadalafil Ketolactam ;

(6R,8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-6,11-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:132160-74-8
MTS44 :
Mometasone Furoate 6beta-Hydroxy Impurity ;

(6R,8S,9S,10R,11S,13S,14S,17R)-17-Acetyl-11,17-dihydroxy-6,10,13-trimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one ;
CAS:187244-73-1
MPS63 :
Methylprednisolone RC 3 ;

(6R,8S,9S,10R,13S,14S,17S)-17-Acetyl-6-hydroxy-10,13-dimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one ;
CAS:604-19-3
PGR62 :
Progesterone 6+¦-Hydroxy ;

(6R,9R)-6-(2,3-Difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one ;
CAS:1397526-07-6
RMG66 :
Rimegepant RC 6 ;

(6R,9S)-6-(2,3-Difluorophenyl)-9-(triisopropylsilyloxy)-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one ;
CAS:1397526-11-2
RMG64 :
Rimegepant RC 4 ;

(6RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2,6-dimethyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one ;
CAS:1346602-28-5
RSP05 :
Risperidone EP Impurity E ; Risperidone 6-Methyl Impurity ; 2,6-Dimethyl Risperidone ;

(6RS)-6-Amino-2-methylheptan-2-ol hydrochloride ;
CAS:543-15-7
HMN00H :
Heptaminol HCl ;

(6RS,12bR)-6-(1,3-Benzodioxol-5-yl)-12-hydroxy-2-methyl-2,3,6,12b-tetrahydropyrazino[1GÇ¦,2GÇ¦:1,5]pyrrolo[3,4-b]quinoline-1,4-dione ;
CAS:2520114-46-7
TLF07 :
Tadalafil EP Impurity G ;

(6S)-2-(3-Chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide ;
CAS:869901-69-9
RGV65 :
Raltegravir RC 5 ;

(6S)-3-Bromo-1'-(2-trimethylsilylethoxymethyl)spiro[5,7-dihydrocyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-2'-one ;
CAS:1318252-70-8
UBG64 :
Ubrogepant RC 4 ;

(6S)-5,6,7,8-Tetrahydro-6-[[2-(2-thienyl)ethyl]amino]-1-naphthalenol ;
CAS:153409-14-4
RTG03B :
Rotigotine EP Impurity C (Base) ; Rotigotine USP RC C (Base) ; N-Despropyl Rotigotine ;

(6S)-5,6,7,8-Tetrahydro-6-[[2-(2-thienyl)ethyl]amino]-1-naphthalenol HCl ;
RTG03H :
Rotigotine EP Impurity C (HCl) ; Rotigotine USP RC C (HCl) ; N-Despropyl Rotigotine HCl ;

(6S)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol ;
CAS:99755-59-6
RTG00B :
Rotigotine (Base) ; (S)-Rotigotine ;

(6S)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol HCl ;
CAS:125572-93-2
RTG00H :
Rotigotine (HCl) ; (S)-Rotigotine HCl ;

(6S)-6-[Ethyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-ol ;
CAS:1369625-04-6
RTG04B :
Rotigotine EP Impurity D (Base) ; Rotigotine N-Ethyl Analog ; Rotigotine Ethyl Analog (USP) ;

(6S)-6-[Ethyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-ol HCl ;
CAS:1369532-05-7
RTG04H :
Rotigotine EP Impurity D (HCl) ; Rotigotine N-Ethyl Analog (HCl) ; Rotigotine Ethyl Analog (HCl) ;

(6S)-6-[Propyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-yl 4-methylbenzenesulfonate ;
RTG09B :
Rotigotine EP Impurity I (Base) ; Rotigotine Toluene Sulfonic Acid Ester ; Rotigotine O-Tosylate ;

(6S)-6-[Propyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-yl 4-methylbenzenesulfonate oxalate ;
RTG09X :
Rotigotine EP Impurity I (Oxalate) ; Rotigotine Toluene Sulfonic Acid Ester (Oxalate) ; Rotigotine O-Tosylate (Oxalate) ;

(6S)-6-[Propyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-yl acetate ;
CAS:835654-68-7
RTG06B :
Rotigotine EP Impurity F (Base) ; O-Acetyl Rotigotine (USP) ;

(6S)-6-[Propyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-yl acetate hydrochloride ;
CAS:1229620-82-9
RTG06H :
Rotigotine EP Impurity F (HCl) ; O-Acetyl Rotigotine (HCl) ;

(6S)-6-[Propyl[2-(thiophen-2-yl)ethyl]amino]-5,6,7,8-tetrahydronaphthalen-1-yl acetate oxalate ;
RTG06X :
Rotigotine EP Impurity F (Oxalate) ; O-Acetyl Rotigotine (Oxalate) ;

(6S)-6-N-[3-[(6S)-2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine ;
CAS:1973461-14-1
PMP03B :
Pramipexole EP Impurity C (Base) ; Pramipexole C-C Dimer ;

(6S)-6-N-[3-[(6S)-2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrochloride ;
PMP03H :
Pramipexole EP Impurity C (2HCl) ; Pramipexole C-C Dimer (2HCl) ;

(6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole ;
CAS:14769-73-4
LVM00B :
Levamisole (Base) ;

(6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride ;
CAS:16595-80-5
LVM00H :
Levamisole HCl ;

(6S,12aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:171596-28-4
TLF03 :
Tadalafil EP Impurity C ; Tadalafil (S,R)-Diastereomer (USP) ; Tadalafil (6S,12aR)-Isomer ; cis-ent-Tadalafil ;

(6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydro pyrazino [1GÇ¦,2GÇ¦:1,6]pyrido[3,4-b]indole-1,4-dione ;
CAS:629652-72-8
TLF02 :
Tadalafil EP Impurity B ; Tadalafil Enantiomer (USP) ; Tadalafil (6S,12aS)-Isomer ; L-Tadalafil ; L-Tildenafil ;

(6S,12bR)-6-(1,3-Benzodioxol-5-yl)-12-hydroxy-2-methyl-2,3,6,12b-tetrahydropyrazino[1GÇ¦,2GÇ¦:1,5]pyrrolo[3,4-b]quinoline-1,4-dione ;
CAS:531500-48-8
TLF47 :
Tadalafil EP Impurity G (6S)-Isomer ;

(6S,6`S,8S,8`S,9R,9'R,10S,10`S,11S,11`S,13S,13`S,14S,14`S,16R,16`R,17R,17`R)-((Methylenebis(sulfanediyl))bis(carbonyl))bis(6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanth
CAS:192191-51-8
FLT61 :
Fluticasone RC 1 ;

(6S,7R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol ;
CAS:2166216-34-6
PMP26B :
Pramipexole USP RC F ; Pramipexole Impurity F ; Pramipexole 7-Hydroxy trans-Isomer ; Pramipexole (7R)-Hydroxy Impurity ;

(6S,7R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol and enantiomer ;
CAS:1246818-51-8
PMP58B :
Pramipexole 7-Hydroxy trans-Racemate ;

(6S,7R)-4,5,6,7-Tetrahydro-N6-propyl-N7-[(6S)-4,5,6,7-tetrahydro-6-(propylamino)-2-benzothiazolyl]-2,6,7-benzothiazoletriamine ;
CAS:1244656-98-1
PMP33B :
Pramipexole C-N Dimer ;

(6S,7S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)-7-benzothiazolol ;
CAS:1001648-71-0
PMP27B :
Pramipexole USP RC G ; Pramipexole Impurity G ; Pramipexole 7-Hydroxy cis-Isomer ; Pramipexole (7S)-Hydroxy Impurity ;

(6S,8R)-8-Hydroxy-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide ;
FTT63 :
Frovatriptan (8R)-Hydroxy Impurity ; Frovatriptan Impurity 13 ;

(6S,8S)-8-Hydroxy-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide ;
FTT64 :
Frovatriptan (8S)-Hydroxy Impurity ; Frovatriptan Impurity 14 ;

(6S,8S,10R,13S,14S,17R)-17-Acetyl-17-hydroxy-6,10,13-trimethyl-7,8,13,15,16,17-hexahydro-6H-cyclopenta[a]phenanthren-3(10H,12H,14H)-one ;
FML05 :
Fluorometholone Impurity E ; Fluorometholone 9,11-Delta Impurity ;

(6S,8S,9R,10S,11S,13S,14S)-17-Acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthren-3(10H)-one ;
CAS:2061-13-4
FML06 :
Fluorometholone Impurity F ; Fluorometholone 16,17-Delta Impurity ;

(6S,8S,9R,10S,11S,13S,14S,16R)-2-Chloro-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione ;
CAS:136132-00-8
HMT61 :
Halometasone RC 1 ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-((Chloromethylthio)carbonyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl acetate ;
CAS:80474-07-3
FLT40 :
Fluticasone Acetate Chloromethyl Analog ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-((Chloromethylthio)carbonyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:1374153-88-4
FLT69 :
Fluticasone RC 9 ; Fluticasone Furoate Chloro ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-Acetoxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbothioic S-acid ;
CAS:80473-93-4
FLT42 :
Fluticasone Carbothioic Acid Acetate ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid ;
CAS:80157-55-7
HMT62 :
Halometasone RC 2 ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-Chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
CAS:50629-82-8
HMT00 :
Halometasone ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbonyl chloride ;
FLT51 :
Fluticasone 17-Chlorocarbonyl Analog ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic dimethylcarbamic thioanhydride ;
CAS:709002-84-6
FLT63 :
Fluticasone RC 3 ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic dimethylcarbamic thioanhydride ;
CAS:105638-31-1
FLT65 :
Fluticasone RC 5 ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11-hydroxy-17-((iodomethylthio)carbonyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl acetate ;
CAS:80474-71-1
FLT41 :
Fluticasone Acetate Iodomethyl Analog ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11-hydroxy-17-((iodomethylthio)carbonyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:80474-67-5
FLT49 :
Fluticasone Propionate Iodomethyl Analog ; Iodofluticasone Propionate (USP) ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:22593-10-8
FLT64 :
Fluticasone RC 4 ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:398454-98-3
FLT68 :
Fluticasone RC 8 ; 1,2-Dihydro Fluticasone Furoate ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-((fluoromethoxy)carbonothioyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
FLT10 :
Fluticasone Propionate EP Impurity J ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-((fluoromethoxy)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:572880-17-2
FLT71 :
Fluticasone RC 11 ; Fluticasone O-Fluoro Methyl Ester ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-((fluoromethyl thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:397864-44-7
FLF00 :
Fluticasone Furoate ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-((fluoromethylthio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl isobutyrate ;
CAS:1648562-63-3
FLT52 :
Fluticasone 17-Isobutyrate ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-((furan-2-carbonyl)oxy)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbo(thioperoxoic )O-acid ;
CAS:948566-11-8
FLT70 :
Fluticasone RC 10 ; Fluticasone Furoate Sulfenic Acid ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6-Chloro-9-fluoro-17-((fluoromethylthio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
FLT11 :
Fluticasone Propionate EP Impurity K ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-6,11-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:134429-33-7
MTS43 :
Mometasone Furoate 6alpha-Hydroxy Impurity ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-Fluoromethyl 6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate ;
CAS:1174034-79-7
FLT56 :
Fluticasone Propionate Fluoromethyl Ester Analog ;

(6S,8S,9R,10S,11S,13S,14S,16R,17R)-Methyl 6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate ;
CAS:59860-80-9
FLT57 :
Fluticasone Propionate Methyl Ester Analog ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
CAS:98651-66-2
HBS50 :
Halobetasol ; 21-Chloro Diflorasone ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:66852-54-8
HBS00 :
Halobetasol Propionate ; Halobetasol 17-Propionate ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-17-(2-(methylsulfonyloxy)acetyl)-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:84509-92-2
HBS54 :
Halobetasol Propionate 21-Mesylate ; Diflorasone 17-Proprionate 21-Mesylate ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:924726-89-6
HBS53 :
Halobetasol Propionate 21-Hydroxy Analog ; Diflorasone 17-Propionate ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Chloro-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
HBS56 :
Halobetasol Propionate 6-Chloro Analog ; 6-Chloro Halobetasol Propionate (USP) ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Chloro-9-fluoro-11-hydroxy-10,13,16-trimethyl-17-(2-(methylsulfonyloxy)acetyl)-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
HBS68 :
Halobetasol Propionate 6-Chloro 21-Mesylate ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-9-Chloro-17-(2-chloroacetyl)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:66852-61-7
HBS59 :
Halobetasol Propionate 9-Chloro Analog ; 9-Chloro Halobetasol Propionate (USP) ; Halobetasol Propionate Impurity D ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-9-Chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-17-(2-(methylsulfonyloxy)acetyl)-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
HBS69 :
Halobetasol Propionate 9-Chloro 21-Mesylate ;

(6S,8S,9R,10S,11S,13S,14S,16S,17R)-9-Chloro-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:84509-91-1
HBS55 :
Halobetasol Propionate 9-Chloro 21-Hydroxy Analog ; 9-Chloro Diflorasone Propionate ;

(6S,8S,9R,10S,11S,13S,14S,17R)-17-Acetyl-9-chloro-11,17-dihydroxy-6,10,13-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
FML03 :
Fluorometholone Impurity C ; Fluorometholone 9-Chloro Analog ;

(6S,8S,9R,10S,11S,13S,14S,17R)-6,9-Difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
CAS:806-29-1
IFP62 :
Isoflupredone RC 2 ; 6+¦-Fluoro Isoflupredone ; 6+¦,GÇï9+¦-GÇïDifluoroprednisolone ;

(6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-((fluoromethylthio)carbonyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:397864-56-1
FLT67 :
Fluticasone RC 7 ; Fluticasone 11-Keto Impurity ;

(6S,8S,9S,10R,11S,13S,14S,17R)-17-Acetyl-11,17-dihydroxy-6,10,13-trimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one ;
CAS:7055-53-0
MPS62 :
Methylprednisolone RC 2 ;

(6S,8S,9S,10R,11S,13S,14S,17S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-6,10,13-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
CAS:1338549-01-1
MPS61 :
Methylprednisolone RC 1 ;

(6S,8S,9S,10R,13S,14S,17S)-17-Acetyl-6-hydroxy-10,13-dimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one ;
CAS:604-20-6
PGR61 :
Progesterone 6+¦-Hydroxy

(7++)-7-O-Demethyl-rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate] ;
CAS:408321-08-4
TSL70 :
Temsirolimus 7-O-Desmethyl ;

(7+¦,15+¦,25R)-7,15-Dihydroxy-3,11,23-trioxolanost-8-en-26-oic acid ; (2R,6R)-6-((5R,7S,10S,13R,14R,15S)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-
CAS:81907-62-2
GDR51 :
Ganoderic Acid A ;

(7-Chloro-1-benzothiophen-3-yl)methanol ;
CAS:142181-53-1
SCZ03 :
Sertaconazole EP Impurity C ;

(7R,8R,9S,13S,14S)-3-Hydroxy-13-methyl-7-(9-((R)-4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one ;
CAS:403656-89-3
FVT51 :
Fulvestrant 17-Ketone ;

(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-(9-((R)-4,4,5,5,5-pentafluoropentyl sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl hydrogen sulfate ;
CAS:261506-26-7
FVT54A :
Fulvestrant 3-Sulfate (Acid) ;

(7R,8R,9S,13S,14S,17S)-3-(Benzyloxy)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol ;
FVT52 :
Fulvestrant 3-O-Benzyl Impurity ;

(7R,8R,9S,13S,14S,17S)-3-Methoxy-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol ;
CAS:1221256-46-7
FVT53 :
Fulvestrant 3-O-Methyl Impurity ;

(7S,12aRa)-7-Amino-3-(+ƒ-D-glucopyranosyloxy)-1,2-dimethoxy-10-(methylsulfanyl)-6,7-dihydrobenzo[a]heptalen-9(5H)-one ;
CAS:177991-81-0
TCS07 :
Thiocolchicoside EP Impurity G ; N-Desacetyl Thiocolchicoside ;

(7S,8R)-3-[2-(tert-Butylamino)acetamido]-7-[[4-carbamoyl-2-(dimethylamino)-3,5,6-trihydroxyphenyl]methyl]-6-carboxy-5,8-dihydroxy-N,Ndimethyl-4-oxo-7,8-dihydronaphthalen-1(4H)-iminium ;
CAS:1138343-10-8
TGC04B :
Tigecycline EP Impurity D (Base) ;

(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-Cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triacont
CAS:61379-65-5
RFT00 :
Rifapentine ;

(7S,9E,11S,12S,13S,14R,15R,16R,17S,18S,19E,21E)-26-[(Z)-(4-Cyclopentylpiperazin-1-yl)iminomethyl]-2,13,15,17,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,
CAS:79039-56-8
RFT50 :
Rifapentine 25-Desacetyl ;

(8aGÇ¦R)-6GÇ¦-(1,3-Benzodioxol-5-yl)-2GÇ¦-methyl-2GÇ¦,3GÇ¦,8GÇ¦,8aGÇ¦-tetrahydro-6GÇ¦H-spiro[3,1-benzoxazine-4,7GÇ¦-pyrrolo[1,2a]pyrazine]-1GÇ¦,2,4GÇ¦(1H)-trione ;
CAS:2747958-44-5
TLF06 :
Tadalafil EP Impurity F ;

(8aGÇ¦R)-6GÇ¦-(1,3-Benzodioxol-5-yl)-2GÇ¦-methyl-2GÇ¦,3GÇ¦,8GÇ¦,8aGÇ¦-tetrahydro-6GÇ¦H-spiro[indole-3,7GÇ¦-pyrrolo[1,2-a]pyrazine]-1GÇ¦,2,4GÇ¦(1H)-trione ;
CAS:2378614-29-8
TLF09 :
Tadalafil EP Impurity I ; Tadalafil Spirooxindole (USP) ;

(8aS)-2-(2,6-Dimethylphenyl)-3,3-dimethylhexahydroimidazo[1,5-a]pyridin-1(5H)-one (Acetone Adduct) ;
CAS:1945965-95-6
RPV06B :
Ropivacaine EP Impurity F ;

(8R)-3-(2-Deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol ;
CAS:53910-25-1
PTS00 :
Pentostatin ; 2-Deoxycoformycin ;

(8R)-9-(6-Amino-9H-purin-9-yl)-5-ethoxy-8-methyl-2,4,7-trioxa-5-phosphanonanoic acid methyl 1-methylethyl ester 5-oxide ;
CAS:1796539-92-8
TNF57B :
Tenofovir Monoisoproxil Ethoxy Impurity ;

(8R,9S,10R,13S,14S,17R)-13-Methyl-17-vinyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol ; 19-Nor-17+¦-pregna-4,20-dien-17-ol ;
CAS:5225-38-7
LNS03 :
Lynestrenol EP Impurity C ; 20,21-Dihydro Lynestrenol ;

(8R,9S,10R,13S,14S,17R)-17-Ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol ; 19-Norpregn-4-en-20-yn-17-ol ;
CAS:58311-09-4
LNS02 :
Lynestrenol EP Impurity B ; Lynestrenol 17-Epimer ;

(8R,9S,10R,13S,14S,17S)-13-Ethyl-17-ethynyl-3-methoxy-2,7,8,9,10,11,12,13,14,17-decahydro-1H-cyclopenta[a]phenanthren-17-ol ;
GTD53 :
Gestodene Dienol 3-Methyl Ether ;

(8R,9S,10R,13S,14S,17S)-17-Ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol ;
CAS:52-76-6
LNS00 :
Lynestrenol ;

(8R,9S,13S,14S,17S)-17-Methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene ;
CAS:39219-28-8
PMS00 :
Promestriene ;

(8S)-7-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acid
CAS:83507-88-4
SPP02 :
Spirapril EP Impurity B ; Spiraprilat ;

(8S,10S,13S,14S,16R,17R)-10,13,16-Trimethyl-17-(2-(methylsulfonyloxy)acetyl)-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:83880-63-1
MTS61 :
Mometasone RC 1 ;

(8S,10S,13S,14S,16R,17R)-17-(2-Acetoxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:83880-61-9
MTS63 :
Mometasone RC 3 ;

(8S,10S,13S,14S,16R,17R)-17-(2-Hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:83880-62-0
MTS62 :
Mometasone RC 2 ;

(8S,13S,14S,17S)-17-Methoxy-13-methyl-3-propoxy-7,8,12,13,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthrene ;
PMS50 :
Promestriene Dehydro Impurity ; Delta-9,11 Promestriene ;

(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-11-hydroxy-17-(2-hydroxyacetyl)-13,16-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
MTS51 :
Mometasone Furoate Impurity 1 ;

(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3,6-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:3068810-13-6
FLT60 :
Fluticasone Propionate 6-Oxo Analog ; 6-Keto Fluticasone Propionate (USP) ; 6-Defluoro-6-Oxo-Fluticasone Propionate ;

(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-17-((fluoromethylthio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:80474-13-1
FLT62 :
Fluticasone RC 2 ;

(8S,9R,10S,11S,13S,14S,16R,17S)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-6,10,13,16-tetramethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
MTS56 :
Mometasone Furoate Impurity 6 ;

(8S,9R,10S,11S,13S,14S,16R,17S)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl acetate ;
CAS:3925-42-6
TCN51
Triamcinolone 16-Acetate ; Triamcinolone Impurity 1 ;

(8S,9R,10S,11S,13S,14S,17R)-17-(2-(1-Ethoxyethoxy)acetyl)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
IFP63 :
Isoflupredone RC 3 ;

(8S,9R,10S,11S,13S,14S,17R)-17-(2-Chloroacetyl)-9-fluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
CAS:68791-68-4
IFP61 :
Isoflupredone RC 1 ;

(8S,9R,10S,11S,13S,14S,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
CAS:1404070-67-2
MTS59 :
Mometasone Furoate Impurity 9 ;

(8S,9R,10S,11S,13S,14S,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ;
CAS:338-95-4
IFP00 :
Isoflupredone ;

(8S,9R,10S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate ;
MTS54 :
Mometasone Furoate Impurity 4 ;

(8S,9S,10R,11R,13S,14S,17S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one ;
HCS62 :
Hydrocortisone RC 2 ; Hydrocortisone Glyoxal Hydrate Isomer-II ;

(8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-1,7,8,9,10,11,12,13,15,16-decahydro-2H-cyclopenta[a]phenanthrene-3,17(6H,14H)-dione ;
HCS63 :
Hydrocortisone RC 3 ; 7-Keto Hydroxyprogesterone ;

(8S,9S,10R,11S,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthren-3(10H)-one ;
PNS57 :
Prednisolone 16,17-Dehydro 21-Hydroxy ;

(8S,9S,10R,11S,13S,14S,17R)-Chloromethyl 17-(ethoxycarbonyloxy)-11-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate ;
CAS:82034-20-6
LTP54 :
Loteprednol Etabonate 1,2-Dihydro ;

(8S,9S,10R,11S,13S,14S,17R)-Ethyl 17-(ethoxycarbonyloxy)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate ;
CAS:182069-19-8
LTP23 :
Loteprednol Etabonate USP RC C ; Loteprednol Etabonate Ethyl Ester ;

(8S,9S,10R,11S,13S,14S,17R)-Iodomethyl 17-((Ethoxycarbonyl)oxy)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate ;
LTP53 :
Loteprednol Etabonate Iodomethyl Analog ;

(8S,9S,10R,13S,14S,17R)-Chloromethyl 17-((ethoxycarbonyl)oxy)-10,13-dimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate ;
CAS:207670-54-0
LTP28 :
Loteprednol Etabonate USP RC H ; 11-Keto Loteprednol Etabonate ;

(8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthrene-3,6(9H,14H)-dione ;
CAS:2243-08-05 00:00:00
PGR60 :
Progesterone 6-Keto ;

(8S,9S,10S,13S,14S,17S)-17-Ethynyl-10-hydroxy-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate ;
NEA60 :
Norethindrone Acetate 10+¦-Hydroxy Impurity ;

(9+¦,11+¦)-9,11-Epoxy-17,21-dihydroxypregn-4-ene-3,20-dione; 9+¦,11+¦-Epoxy-17,21-dihydroxypregn-4-ene-3,20-dione ;
CAS:10072-97-6
HCS50 :
Hydrocortisone Epoxide Impurity ; Hydrocortisone 9,11-Epoxide ; Hydrocortisone 9beta,11beta-Epoxide ;

(9+¦,11+¦)-9,11-Epoxy-21-hydroxy-pregna-1,4,16-triene-3,20-dione ;
CAS:103466-44-0
PNS56 :
Prednisolone Anhydro Epoxide ;

(9E)-9-[O-[(2-Methoxyethoxy)methyl]oxime] Erythromycin ;
CAS:80214-83-1
RTM00 :
Roxithromycin ;

(9RS)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one ;
CAS:144598-75-4
RSP03 :
Risperidone EP Impurity C ; 9-Hydroxy Risperidone ; Paliperidone ;

(9RS)-9-[3-(Dimethylamino)propyl]-2-(trin¼éuoromethyl)-9H-thioxanthen-9-ol ;
CAS:23904-98-5
FPX01 :
Flupentixol EP Impurity A ;

(9S)-6GÇÖ-Methoxycinchonan-9-ol ; (S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol ;
CAS:56-54-2
QND00B :
Quinidine (Base) ;

(9S)-6GÇÖ-Methoxycinchonan-9-ol ; (S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol sulfate salt ;
CAS:747-45-5
QND00S :
Quinidine (Sulfate) ;

(9S)-6GÇÖ-Methoxycinchonan-9-ol ; (S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol sulfate salt dihydrate ;
CAS:6591-63-5
QND00D :
Quinidine (Sulfate Dihydrate) ;

(9S)-6GÇÖ-Methoxycinchonan-9-ol ; (S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol sulfate salt monohydrate ;
CAS:6119-70-6
QND00M :
Quinidine (Sulfate Monohydrate) ;

(9S)-6GÇÖ-Methoxycinchonan-9-ol 1-Oxide ;
CAS:70116-00-6
QND50 :
Quinidine N-Oxide ;

(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-Trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1GÇ¦-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2GÇ¦,3GÇ¦:7,8]naphtho[1,2-
CAS:72559-06-9
RFB00 :
Rifabutin ;

(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-
CAS:645406-37-7
RFB50 :
Rifabutin N-Oxide ;

(9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-+¦-[(dibutylamino)methyl]-9H-fluorene-4-methanol +¦-D-glucopyranosiduronic acid ;
LFN60 :
Lumefantrine +¦-D-Glucuronide ;

(9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-+¦-[(dibutylamino)methyl]-9H-fluorene-4-methanol ;
CAS:82186-77-4
LFN00 :
Lumefantrine ;

(Carbamoylamino)(diphenyl)acetic acid ;
CAS:6802-95-5
PNT05 :
Phenytoin EP Impurity E ; Phenytoin BP Impurity E ; Phenytoin USP RC B ;

(Diethoxyphosphoryl)methyl 4-methylbenzenesulfonate ;
CAS:31618-90-3
TNF97 :
Tenofovir RC 7 ;

(E)-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3-hydroxy-5-oxo-6-heptenoic acid ;
CAS:1160169-39-0
FLV04 :
Fluvastatin EP Impurity D ; Fluvastatin BP Impurity D ; rac 5-Keto Fluvastatin ; 3-Hydroxy-5-Keto Fluvastatin (USP) ;

(E)-(2,4-Difluorophenyl)(piperidin-4-yl)methanone oxime ;
CAS:691007-07-5
RSP82 :
Risperidone RC 12 ;

(E)-(2-Aminoethyl)(2-(((5-methoxy-1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)carbamic acid ;
FVX64 :
Fluvoxamine Impurity 4 ; Fluvoxamine N-Carbamate N-Ethylamino ;

(E)-(R)-5-Biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pent-2-enoic acid ethyl ester ;
SCT99 :
Sacubitril RC 29 ;

(E)-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic acid ;
CAS:53933-60-1
SDC01 :
Sulindac EP Impurity A ; Sulindac USP RC A ; Sulindac (E)-Isomer ;

(E)-1,1,1-Trichloro-4-ethoxybut-3-en-2-one ;
CAS:83124-74-7
RGD64 :
Regadenoson Impurity 14 ;

(E)-1,2-Bis(4-methoxyphenyl)ethene ;
CAS:4705-34-4
RLX69 :
Raloxifene RC 9 ;

(E)-1-((4-Hydroxy-5-nitrofuran-2-yl)methyleneamino)imidazolidine-2,4-dione ;
CAS:76644-41-2
NFR54 :
Nitrofurantoin 4-Hydroxy Impurity ;

(E)-1-((5-Nitrofuran-2-yl)methyleneamino)imidazolidine-2,4-dione ;
CAS:67-20-9
NFR00A :
Nitrofurantoin (Anhydrous) ;

(E)-1-((5-Nitrofuran-2-yl)methyleneamino)imidazolidine-2,4-dione monohydrate ;
CAS:17140-81-7
NFR00H :
Nitrofurantoin (Monohydrate) ;

(E)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone O-2,4-dichlorobenzyl oxime ;
CAS:76472-50-9
OCZ21 :
Oxiconazole USP RC A ; Oxiconazole (E)-Isomer ;

(E)-1-(2,6-Dimethylphenoxy)propan-2-one oxime ;
CAS:55304-19-3
MLT67 :
Mexiletine RC 7 ;

(E)-1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one ;
CAS:1214-47-7
PRP61 :
Propafenone RC 1 ;

(E)-1-(3-Chloroallyl)-2-methyl-5-nitro-1H-imidazole ;
CAS:1384752-15-1
ODZ63 :
Ornidazole RC 3 ;

(E)-1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone-O-(4-cyclohexyl-3-(trifluoromethyl)benzyl)oxime ;
CAS:800379-63-9
SNM65 :
Siponimod RC 5 ;

(E)-1-(4-((5-Fluoro-2-hydroxyphenyl)(hydroxyimino)methyl)piperidin-1-yl)ethanone ;
CAS:84162-97-0
RSP76 :
Risperidone RC 6 ;

(E)-1-(4-(1-(4-Cyclohexyl-3-(trifluoromethyl)benzyloxyimino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid ;
CAS:1230487-00-9
SNM00 :
Siponimod ;

(E)-1-(4-Methoxystyryl)-3,5-dimethoxybenzene ;
CAS:22255-22-7
RVT64 :
Resveratrol Trimethyl Ether Impurity ; Resveratrol Trimethoxy Impurity ;

(E)-1-(9-(4-Chlorobenzylidene)-2,7-dichloro-9H-fluoren-4-yl)-2-(dibutylamino)ethanol ;
CAS:1456736-33-6
LFN59 :
Lumefantrine (9E)-Isomer ;

(E)-1-[3-(Benzyloxy)phenyl]-2-(hydroxyimino)propan-1-one ;
MRN21 :
Metaraminol USP RC A ;

(E)-1-[4-[[6-O-(6-Deoxy-+¦-L-mannopyranosyl)-+ƒ-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-2-propen-1-one ;
CAS:24292-52-2
HSP51 :
Hesperidin Methyl Chalcone ;

(E)-1-{3-[2-(7-Chloroquinolin-2-yl)vinyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propan-1-one ;
CAS:1258428-71-5
MTL63 :
Montelukast Ketone Impurity (USP) ; Montelukast 3-Oxo Propanol Impurity ;

(E)-1-Acetyl-N-(acetyloxy)-+¦-(5-fluoro-2-hydroxyphenyl)-4-piperidinemethanimine ;
CAS:84163-52-0
RSP75 :
Risperidone RC 5 ;

(E)-1-Chloro-6,6-dimethylhept-2-en-4-yne ;
CAS:287471-30-1
TBN77 :
Terbinafine RC 17 ;

(E)-2,2,2-Trifluoro-N'-(1-nitrosopiperazin-2-ylidene)acetohydrazide ;
SGT72 :
Sitagliptin Impurity 12 ;

(E)-2,2,2-Trifluoro-N'-(piperazin-2-ylidene)acetohydrazide ;
CAS:849832-73-1
SGT51B :
Sitagliptin Acetohydrazide Impurity ;

(E)-2,2-Dimethyl-7-(methyl(naphthalen-1-ylmethyl)amino)hept-5-en-3-yn-1-ol ;
CAS:162227-13-6
TBN53 :
Terbinafine Hydroxy Impurity ;

(E)-2,2-Dimethyl-7-(methyl(naphthalen-1-ylmethyl)amino)hept-5-en-3-ynyl benzoate ;
CAS:1076198-30-5
TBN55 :
Terbinafine Hydroxy Benzoate ;

(E)-2,2-Dimethyl-7-(naphthalen-1-ylmethylamino)hept-5-en-3-yn-1-ol ;
CAS:162227-14-7
TBN57 :
Terbinafine N-Desmethyl Hydroxy Impurity ;

(E)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine ;
CAS:196597-61-2
RMT89 :
Ramelteon RC 19 ;

(E)-2-(1-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4-mercaptopiperidin-3-ylidene)acetic acid ;
PRS56 :
Prasugrel R-138727 Metabolite (E)-Isomer ; (E)-Prasugrel Thiol Analog ;

(E)-2-(1-(4-Hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)ethylideneamino)acetic acid ;
RXD74 :
Roxadustat RC 14 ;

(E)-2-(1-Carbamoyl-2-((5-nitrofuran-2-yl)methylene)hydrazinyl)acetic acid ;
CAS:63981-22-6
NFR21 :
Nitrofurantoin USP RC A ;

(E)-2-(1H-Indol-5-yl)-N-methylethenesulfonamide ;
CAS:1305334-90-0
NRT63 :
Naratriptan RC 3 ;

(E)-2-(2-((5-Nitrofuran-2-yl)methylene)hydrazinyl)acetic acid ;
CAS:91447-38-0
NFR62A :
Nitrofurantoin RC 2 (Acid) ;

(E)-2-(2-((5-Nitrofuran-2-yl)methylene)hydrazinyl)acetic acid sodium salt ;
CAS:150870-92-1
NFR62N :
Nitrofurantoin RC 2 (Sodium Salt) ;

(E)-2-(2-(Phthalazin-1-yl)hydrazono)propanoic acid ;
CAS:67536-13-4
HDL58A :
Hydralazine Pyruvic Acid Hydrazone ;

(E)-2-(2-(Phthalazin-1-yl)hydrazono)propanoic acid sodium salt ;
CAS:96253-92-8
HDL58N :
Hydralazine Pyruvic Acid Hydrazone (Sodium) ;

(E)-2-(2-{[(Dimethylamino)methylidene]amino}propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide ;
CAS:1193687-85-2
RGV02 :
Raltegravir EP Impurity B ; Raltegravir USP Impurity C ; Raltegravir Formididyl Analog ;

(E)-2-(3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-7,8-dihydro-4H-pyrido[1,2-a]pyrimidin-9(6H)-ylidene)acetic acid ;
RSP62 :
Risperidone 9-Ethylidenecarboxylate Impurity ;

(E)-2-(3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-7,8-dihydro-4H-pyrido[1,2-a]pyrimidin-9(6H)-ylidene)acetic acid ;
RSP51 :
Risperidone Acetic Acid (E)-Isomer ;

(E)-2-(3-(Pyrrolidin-1-yl)-1-p-tolylprop-1-enyl)pyridine ;
CAS:486-12-4
TDN00B :
Triprolidine (Base) ; trans-Triprolidine ; (E)-Triprolidine ;

(E)-2-(3-(Pyrrolidin-1-yl)-1-p-tolylprop-1-enyl)pyridine hydrochloride ;
CAS:550-70-9
TDN00H :
Triprolidine HCl ; trans-Triprolidine HCl ; (E)-Triprolidine HCl ;

(E)-2-(3-(Pyrrolidin-1-yl)-1-p-tolylprop-1-enyl)pyridine hydrochloride monohydrate ;
CAS:6138-79-0
TDN00M :
Triprolidine HCl Monohydrate ; trans-Triprolidine HCl Monohydrate ; (E)-Triprolidine HCl Monohydrate ;

(E)-2-(4-((E)-3-((R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxoprop-1-enyl)-2-hydroxyphenoxy)-3-(3,4-dihydroxyphenyl)acrylic acid ;
CAS:150072-80-3
SVN09
Salvianolic Acid I ;

(E)-2-(4-(4-Chloro-1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine ;
TRM60 :
Toremifene (E)-Isomer ;

(E)-2-(5-((E)-3-((R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxoprop-1-enyl)-2-hydroxyphenoxy)-3-(3,4-dihydroxyphenyl)acrylic acid ;
CAS:444179-57-1
SVN08
Salvianolic Acid H ;

(E)-2-(5-Methoxy)phenol 4-(N-benzyloxycarbonyl)piperidinyl-methanone O-acetyl oxime ;
CAS:84163-48-4
RSP93 :
Risperidone RC 23 ;

(E)-2-(6,6-Dimethylhept-2-en-4-ynyl)isoindoline-1,3-dione ;
CAS:123926-46-5
TBN74 :
Terbinafine RC 14 ;

(E)-2-(6-Methoxy-2,3-dihydroinden-1-ylidene)acetonitrile ;
CAS:187871-98-3
RMT87 :
Ramelteon RC 17 ;

(E)-2-(6-methoxy-2,3-dihydroinden-1-ylidene)ethanamine ;
CAS:178676-73-8
RMT85 :
Ramelteon RC 15 ;

(E)-2-(Furan-2-ylmethylsulfinyl)-N-(4-(4-(piperidin-1-ylmethyl)pyridin-2-yloxy)but-2-enyl)acetamide ;
CAS:206449-94-7
LFT50 :
Lafutidine (E)-Isomer ;

(E)-2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide ;
TFM50 :
Teriflunomide (E)-Isomer ; Leflunomide Cyano (E)-Isomer (LFM50) ;

(E)-2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide ;
LFM50 :
Leflunomide (E)-Cyano Metabolite ; Teriflunomide (E)-Isomer ;

(E)-2-Hydroxy-5-((4-(N-(4-(N-(pyridin-2-yl)sulfamoyl)phenyl)sulfamoyl)phenyl)diazenyl)benzoic acid ;
CAS:2033064-44-5
SSZ55 :
Sulfasalazine RC 5 ;

(E)-3-((1R,4S,7R,7aR)-1-Acetoxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl)-2-methylacrylic acid ;
CAS:84638-55-1
VRN50 :
Valerenic Acid Acetoxy Impurity ; Acetoxyvalerenic Acid ;

(E)-3-((4S,7R,7aR)-2-Hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl)-2-methylacrylic acid ;
CAS:1619-16-5
VRN51 :
Valerenic Acid Hydroxy Impurity ; Hydroxy Valerenic acid ;

(E)-3-((4S,7R,7aR)-3,7-Dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl)-2-methylacrylic acid ;
CAS:3569-10-06 00:00:00
VRN00 :
Valerenic Acid ;

(E)-3-((5-Nitrofuran-2-yl)methyleneamino)oxazolidin-2-one ;
CAS:67-45-8
FRZ00 :
Furazolidone ;

(E)-3-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol ;
CAS:82413-20-5
TMX53B :
Tamoxifen 3-Hydroxy trans-Isomer ;

(E)-3-(2-((E)-3,4-Dihydroxystyryl)-3,4-dihydroxyphenyl)acrylic acid ;
CAS:158732-59-3
SVN06
Salvianolic Acid F ;

(E)-3-(2-(4-((4-Fluoro-2-hydroxyphenyl)(hydroxyimino)methyl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one ;
CAS:1391062-47-7
RSP88 :
Risperidone RC 18 ;

(E)-3-(2-Chloro-4-(cyclopentylamino)pyrimidin-5-yl)but-2-enoic acid ;
CAS:2242625-36-9
PBC75 :
Palbociclib RC 15 ;

(E)-3-(2-Chloroethyl)-9-(hydroxyimino)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one ;
CAS:1204248-71-4
PPD62 :
Paliperidone RC 2 ;

(E)-3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)acrylaldehyde ;
CAS:93957-50-7
FLV51 :
Fluvastatin Aldehyde Impurity ;

(E)-3-(3-Bromo-4,5-dimethoxyphenyl)-2-(methoxymethyl)acrylonitrile ;
TMM51 :
Trimethoprim Impurity 1 ;

(E)-3-(3-Methylpyridin-2-ylamino)-2-(1H-tetrazol-5-yl)acrylic acid ;
PML64 :
Pemirolast RC 4 ;

(E)-3-(4-((1H-Imidazol-1-yl)methyl)phenyl)acrylic acid ;
CAS:82571-53-7
OZG00A :
Ozagrel ;

(E)-3-(4-((1H-Imidazol-1-yl)methyl)phenyl)acrylic acid hydrochloride ;
CAS:74003-18-2 78712-43-3
OZG00H :
Ozagrel Hydrochloride ;

(E)-3-(4-(2-(4-Cyanophenylamino)pyrimidin-4-ylamino)-3,5-dimethylphenyl)acrylamide ;
CAS:500288-66-4
RLP53B :
Rilpivirine Acrylamide Impurity ; Rilpivirine 4-Amide (USP) ;

(E)-3-(4-Acetoxystyryl)-5-acetoxyphenyl 4-oxopentanoate ; 4-Oxo-pentanoic acid 3-(Acetyloxy)-5-[(1E)-2-[4-(acetyloxy)phenyl]ethenyl]phenyl Ester ;
CAS:861446-23-3
RVT51 :
Resveratrol 1-O-Levulinoyl Diacetate Impurity ;

(E)-3-(4-Amino-3,5-dimethylphenyl)acrylonitrile Hydrochloride ; (2E)-3-(4-Amino-3,5-dimethylphenyl)prop-2-enenitrile ;
CAS:500292-94-4
RLP54B :
Rilpivirine Acrylonitrile Impurity (Base) ;

(E)-3-(4-Amino-3,5-dimethylphenyl)acrylonitrile Hydrochloride ; (2E)-3-(4-Amino-3,5-dimethylphenyl)prop-2-enenitrile hydrochloride ;
CAS:661489-23-2
RLP54H :
Rilpivirine Acrylonitrile Impurity (HCl) ;

(E)-3-(4-Bromo-3,5-dimethoxyphenyl)-2-(methoxymethyl)acrylonitrile ;
CAS:56518-39-9
TMM52 :
Trimethoprim Impurity 2 ;

(E)-3-(4-Isobutylphenyl)acrylic acid ;
CAS:66734-95-0
IBP64 :
Ibuprofen Impurity 4 ;

(E)-3-(5-(2-Nitroprop-1-enyl)indolin-1-yl)propyl benzoate ;
CAS:350797-53-4
SLD73 :
Silodosin RC 3 ;

(E)-3-(Dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one ;
CAS:123367-26-0
NLT62B :
Nilotinib RC 2 ;

(E)-3-[[(1R,3R,4R)-4-Hydroxy-3-methoxycyclohexyl]-2-methylacrylaldehyde ;
CAS:109466-74-2
TCL51 :
Tacrolimus Methylacryl Aldehyde (USP) ;

(E)-3-Amino-3-imino-2-(phenyldiazenyl)propanamide ;
CAS:100607-08-7
TMZ64B :
Temozolomide RC 4 (Base) ;

(E)-3-Amino-3-imino-2-(phenyldiazenyl)propanamide hydrochloride ;
CAS:6285-64-9
TMZ64H :
Temozolomide RC 4 (HCl) ;

(E)-3-Phenylprop-2-enamide ;
CAS:621-79-4 22031-64-7
MTM01 :
Mitomycin EP Impurity A ; Cinnamamide ;

(E)-4-(((2S,4R)-1-([1,1`-Biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobut-2-enoic acid ;
SCT56 :
Sacubitril Fumaric Analog ;

(E)-4-((1-Methylpiperidin-4-ylimino)methyl)phenol ;
PVN64 :
Pimavanserin RC 4 ;

(E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoic acid ;
CAS:66262-68-8
MPR51 :
Mupirocin Monic Acid A ;

(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)(nitroso)amino)pyrimidin-2-yl)(nitroso)amino)benzonitrile ;
RLP66B :
Rilpivirine RC 6 ; N,N-Dinitroso Rilpivirine ;

(E)-4-((4-(4-(2-Cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-yl)(nitroso)amino)benzonitrile ;
RLP65B :
Rilpivirine RC 5 ;

(E)-4-((4-Acetoxy-3-(methoxycarbonyl)phenyl)diazenyl)benzenesulfonic acid ;
CAS:802901-89-9
SSZ58A :
Sulfasalazine RC 8 (Acid) ;

(E)-4-((4-Hydroxy-3-(methoxycarbonyl)phenyl)diazenyl)benzenesulfonic acid ;
CAS:745010-25-7
SSZ59A :
Sulfasalazine RC 9 (Acid) ;

(E)-4-(1-(4-(2-(Methylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol ;
CAS:114828-90-9
TMX57B :
Tamoxifen 4-Hydroxy N-Desmethyl trans-Isomer ;

(E)-4-(1-Benzyl-2-methyl-1H-imidazol-5-yl)-3-(ethoxycarbonyl)but-3-enoic acid ;
CAS:1640981-02-7
TGP67 :
Tegoprazan RC 7 ;

(E)-4-(2,4,5-Trifluorophenyl)but-2-enoic acid ;
CAS:1840966-95-1
SGT71 :
Sitagliptin Impurity 11 ;

(E)-4-(3,5-Dihydroxystyryl)phenyl hydrogen sulfate ;
CAS:858187-19-6
RVT59 :
Resveratrol 4-Sulfate Impurity ;

(E)-4-(3-Chloro-4-(pyridin-2-ylmethoxy)phenylamino)-7-ethoxy-6-(1-methylpyrrolidin-2-ylideneamino)quinoline-3-carbonitrile ;
CAS:1144516-21-1
NTB59 :
Neratinib Impurity 9 ;

(E)-4-(4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)(nitroso)amino)pyrimidin-2-ylamino)benzonitrile ;
RLP64B :
Rilpivirine RC 4 ;

(E)-4-(4-(3-Chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-ylamino)-N,N,N-trimethyl-4-oxobut-2-en-1-aminium chloride ;
NTB58 :
Neratinib Impurity 8 ;

(E)-4-(4-(4-(2-Cyanovinyl)-2,6-bis(hydroxymethyl)phenylamino)pyrimidin-2-ylamino)benzonitrile ;
RLP51B :
Rilpivirine 2,6-Dihydroxymethyl Impurity ;

(E)-4-(4-(4-(2-Cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzamide ;
CAS:1446439-51-5
RLP62B :
Rilpivirine RC 2 ; Rilpivirine 2-Amide (USP) ;

(E)-4-(4-(4-(2-Cyanovinyl)-2-(hydroxymethyl)-6-methylphenylamino)pyrimidin-2-ylamino)benzonitrile ;
CAS:1798429-64-7
RLP52B :
Rilpivirine 2-Hydroxymethyl Impurity ;

(E)-4-(4-(4-(3-Amino-3-oxoprop-1-enyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzamide ;
CAS:1446690-23-8
RLP61B :
Rilpivirine RC 1 ; Rilpivirine Impurity F ;

(E)-4-(4-Chloro-1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenyl pivalate ;
CAS:177748-20-8
TRM66 :
Toremifene 4-Pivaloyloxy ;

(E)-4-(6-Methoxynaphthalen-2-yl)but-3-en-2-one ;
CAS:56600-90-9 127053-22-9
NBM04 :
Nabumetone EP Impurity D ; Nabumetone USP RC A ; Dehydro Nabumetone ;

(E)-4-(But-1-en-1-yl)-11-cyclopropyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one ;
CAS:284686-27-7 (E/Z)
NVR61 :
Nevirapine Butenyl Impurity ;

(E)-4-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol 1-acetate ;
CAS:76117-70-9
TMX54B :
Tamoxifen (E)-4-Acetoxy Impurity ;

(E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester ;
CAS:103890-78-4
LCD00 :
Lacidipine ;

(E)-4-[3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol ;
CAS:53772-85-3
FPX60B :
Flupentixol trans-Isomer (Base) ; (E)-Flupentixol ;

(E)-4-[3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol dihydrochloride ;
CAS:51529-02-3
FPX60H :
Flupentixol trans-Isomer (2HCl) ; (E)-Flupentixol Dihydrochloride ;

(E)-4-[3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol oxalate ;
FPX60X :
Flupentixol trans-Isomer (Oxalate) ; (E)-Flupentixol Oxalate ;

(E)-4-Ethoxy-3-(pyridin-4-yl)but-3-en-2-one ;
CAS:88349-61-5
MLR51 :
Milrinone RC 1 ;

(E)-4-Ethoxy-4-oxobut-2-enoic acid ; Fumaric Acid Monoethyl Ester ;
CAS:2459-05-04 00:00:00
QTP18 :
Quetiapine EP Impurity R ;

(E)-4-Hydroxy-3-(3-oxo-1-phenylbut-1-enyl)-2H-chromen-2-one ;
CAS:67588-18-5
WFR85 :
Warfarin RC25

(E)-4-Hydroxy-N'-((5-nitrofuran-2-yl)methylene)benzohydrazide ;
CAS:965-52-6
NRX00 :
Nifuroxazide ;

(E)-5-((4-Hydroxyphenyl)diazenyl)benzene-1,3-diol ;
CAS:1393556-48-3
RVT60 :
Resveratrol Azo Impurity ;

(E)-5-(2,4-Dihydroxystyryl)benzene-1,3-diol ;
CAS:29700-22-9
RVT52 :
Resveratrol 2-Hydroxy Impurity ;

(E)-5-(2-Acetamidoethoxyimino)-5-(4-(trifluoromethyl)phenyl)pentanoic acid ;
CAS:88699-87-0
FVX51 :
Fluvoxamine Acid N-Acetyl Impurity ;

(E)-5-(3,4-Dihydroxystyryl)benzene-1,3-diol ;
CAS:10083-24-6
RVT53 :
Resveratrol 3-Hydroxy Impurity ; trans-Piceatannol ;

(E)-5-(4-Bromostyryl)benzene-1,3-diol ;
CAS:1224713-90-9
RVT57 :
Resveratrol 4-Bromo Impurity ;

(E)-5-(4-Hydroxystyryl)benzene-1,3-diol ;
CAS:501-36-0
RVT00 :
Resveratrol ;

(E)-5-(4-Methoxystyryl)benzene-1,3-diol ;
CAS:33626-08-3
RVT58 :
Resveratrol 4-Methyl Ether Impurity ;

(E)-5-Methyl-1-((5-nitrofuran-2-yl)methyleneamino)imidazolidine-2,4-dione ;
CAS:3668-93-7
NFR55 :
Nitrofurantoin 5-Methyl Impurity ;

(E)-6,6'-((Triaz-1-ene-1,3-diylbis(2,6-dichloro-4,1-phenylene))bis(oxy))bis(4-isopropylpyridazin-3(2H)-one) ;
RMR74 :
Resmetirom RC 14 ;

(E)-6,6-Dimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine ;
CAS:99473-11-7
TBN56B :
Terbinafine N-Desmethyl Impurity (Base) ;

(E)-6,6-Dimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine HCl ;
CAS:152830-98-3
TBN56H :
Terbinafine N-Desmethyl Impurity (HCl) ;

(E)-6-(1,3-Dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid ;
CAS:38877-93-9
MCP33 :
Mycophenolic Acid O-Methyl Ether ; O-Methyl Mycophenolic Acid ;

(E)-6-(3-(4-Hydroxystyryl)-5-hydroxyphenoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:387372-17-0
RVT54 :
Resveratrol 3-O-B-D-Glucuronide ;

(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid sorbitol ester ;
MCP50 :
Mycophenolic Acid Sorbitol Ester ; 1-O-D-Sorbitol Mycophenolate ;

(E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-N,N,4-trimethylhex-4-enamide ;
CAS:59058-64-9
MCP39 :
Mycophenolate Dimethylamide ; Mycophenolate Amide Impurity ;

(E)-7-[4-(Trifluoromethyl)phenyl]-5,12-dioxa-2,6-diazatridec-6-enoic acid 9H-fluoren-9-ylmethyl ester ;
FVX54 :
Fluvoxamine N-Fmoc (E)-Isomer ;

(E)-7-Methyloct-3-ene ;
CAS:362046-49-9
PRG88 :
Pregabalin Impurity 28 ;

(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione ;
CAS:155270-99-8
IDF00 :
Istradefylline ;

(E)-8-(3,4-Dimethoxystyryl)-3-ethyl-1-(2-hydroxyethyl)-7-methyl-1H-purine-2,6(3H,7H)-dione ;
CAS:1798429-54-5
IDF48 :
Istradefylline M8 ; Istradefylline Hydroxyethyl Analog ;

(E)-8-(4-Hydroxy-3-methoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione ;
CAS:160434-48-0
IDF40 :
Istradefylline 4-O-Desmethyl Impurity ;

(E)-8-Ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(E)-2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4] oxaazacyclotricosine-1,7
CAS:135635-46-0
TCL21 :
Tacrolimus USP RC A ;

(E)-9-(Prop-1-enyl)-9H-purin-6-amine ;
CAS:4121-40-8 1446486-33-4
TNF81B :
Tenofovir Disoproxil IP Impurity K ; Tenofovir Disoproxil USP RC B ; Tenofovir 9-Propenyl Impurity ; 9-Propenyladenine ;

(E)-Benzyl 4-((2-hydroxy-4-methoxyphenyl)(hydroxyimino)methyl)piperidine-1-carboxylate ;
CAS:84163-47-3
RSP91 :
Risperidone RC 21 ;

(E)-Benzyl 4-hydroxy-7-oxooct-5-enylcarbamate ;
CAS:866488-35-9
HLF68 :
Halofuginone RC 8 ;

(E)-Diethyl 2-((4-carbamoyl-1H-imidazol-5-yl)diazenyl)-2-nitromalonate ;
CAS:287964-47-0
TMZ63 :
Temozolomide RC 3 ;

(E)-Diethyl 4-(2-(3-tert-butoxy-3-oxoprop-1-enyl)phenyl)-3,6-dimethyl-1,4-dihydropyridine-2,5-dicarboxylate ;
CAS:1160755-72-5
LCD50 :
Lacidipine Regio Impurity ;

(E)-Dimethyl 2-((2-(((5-methoxy-1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)amino) succinate ;
FVX62 :
Fluvoxamine Impurity 2 ; Fluvoxamine Succinyl Bis-Methyl Ester ;

(E)-Ethyl 2-cyano-5-methylhex-2-enoate ;
CAS:103011-96-7
PRG78 :
Pregabalin Impurity 18 ;

(E)-Ethyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate ;
CAS:78712-80-8
OZG52B :
Ozagrel Ethyl Ester ;

(E)-Ethyl 4-(tert-butoxycarbonyl)but-2-enoate ;
CAS:104700-36-9
PRG79 :
Pregabalin Impurity 19 ;

(E)-Ethyl N-4-cyclohexyl-3-(trifluoromethyl)benzyloxyacetimidate ;
CAS:1418144-65-6
SNM66 :
Siponimod RC 6 ;

(E)-Methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate ;
CAS:1168152-07-5
NTD73 :
Nintedanib RC 13 ;

(E)-Methyl 2-acetoxy-5-((4-(chlorosulfonyl)phenyl)diazenyl)benzoate ;
CAS:34265-47-9
SSZ53 :
Sulfasalazine RC 3 ;

(E)-Methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate ;
CAS:956932-46-0 866157-50-8
OZG51B :
Ozagrel Methyl Ester ;

(E)-Methyl 3-(4-(bromomethyl)phenyl)acrylate ;
CAS:946-99-6
OST66 :
Oseltamivir RC 6 ;

(E)-Methyl 3-p-tolylacrylate ;
CAS:20754-20-5
OST67 :
Oseltamivir RC 7 ;

(E)-Methyl 5-methylhex-2-enoate ;
CAS:68797-67-1
PRG84 :
Pregabalin Impurity 24 ;

(E)-N'-(1,4-Dinitrosopiperazin-2-ylidene)-2,2,2-trifluoroacetohydrazide ;
SGT73 :
Sitagliptin Impurity 13 ;

(E)-N'-Hydroxy-N-(4-(2-methyl-4-nitrophenoxy)pyridin-2-yl)formamidine ;
CAS:2307628-65-3
TCB67 :
Tucatinib RC 7 ;

(E)-N,6,6-Trimethyl-N-nitrosohept-2-en-4-yn-1-amine ;
TBN59 :
Terbinafine Desnaphthalene N-Nitroso ;

(E)-N,6,6-Trimethylhept-2-en-4-yn-1-amine ;
CAS:83554-69-2
TBN78 :
Terbinafine RC 18 ;

(E)-N,N-Diisopropyl-3-phenylprop-2-en-1-amine ;
CAS:87462-12-2 173948-30-6
TTR68 :
Tolterodine Impurity 8 ;

(E)-N-(2-(((5-Hydroxy-1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)acetamide ;
FVX52 :
Fluvoxamine O-Desmethyl N-Acetyl Impurity ;

(E)-N-(2-(5-Methoxy-2,3-dihydroinden-1-ylidene)ethyl)propionamide ;
CAS:196597-82-7
RMT82 :
Ramelteon RC 12 ;

(E)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide ; N-[2-(Diethylamino)ethyl]-5-[(E)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
SNT01 :
Sunitinib EP Impurity A ; Sunitinib (E)-Isomer ;

(E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)hydroxyamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide ;
NTB53 :
Neratinib Impurity 3 ;

(E)-N-(4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-ylidene)(phenyl)methanamine ;
CAS:335627-22-0
STL61 :
Sertraline RC 1 ;

(E)-N-(4-(3-Chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(methylamino)but-2-enamide ;
CAS:915788-27-1
NTB41 :
Neratinib N-Methyl ;

(E)-N-(4-(7-Chloro-5-methoxy-2,3-dihydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide ;
TVT54 :
Tolvaptan 5-Dehydro Methyl Enol Ether ;

(E)-N-(Naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine hydrochloride ;
CAS:98978-52-0
NTF51H :
Naftifine N-Desmethyl Impurity (HCl) ;

(E)-N-(Naphthalen-2-ylmethylene)methanamine ;
CAS:125660-64-2
TBN64 :
Terbinafine RC 4 ;

(E)-N-[3-(Methylamino)propyl]-3-(thiophen-2-yl)prop-2-enamide ;
CAS:36700-39-7
PTL02B :
Pyrantel EP Impurity B (Base) ;

(E)-N-[3-(Methylamino)propyl]-3-(thiophen-2-yl)prop-2-enamide HCl ;
CAS:1449108-90-0
PTL02H :
Pyrantel EP Impurity B (HCl) ;

(E)-N-[5-Methoxy-1-[4-(trifluoromethyl)phenyl]-pentylidene]hydroxylamine ;
CAS:88699-84-7
FVX09 :
Fluvoxamine EP Impurity I ;

(E)-N-Methyl-N-(3-phenyl-2-propen-1-yl)-1-naphthalenemethanamine ;
CAS:65472-88-0
NTF00B :
Naftifine (Base) ;

(E)-N-Methyl-N-(3-phenyl-2-propen-1-yl)-1-naphthalenemethanamine hydrochloride ;
CAS:65473-14-5
NTF00H :
Naftifine HCl ;

(E)-N-Methyl-N-(3-phenyl-2-propen-1-yl)-1-naphthalenemethanamine N-oxide ;
NTF52 :
Naftifine N-Oxide ;

(E)-N-Methyl-N-(naphthalen-2-ylmethyl)-3-phenylprop-2-en-1-amine ;
CAS:98977-54-9
NTF63B :
Naftifine RC 3 (Base) ;

(E)-N-Methyl-N-(naphthalen-2-ylmethyl)-3-phenylprop-2-en-1-amine HCl ;
NTF63H :
Naftifine RC 3 (HCl) ;

(E)-tert-Butyl 3-(2-formylphenyl)acrylate ;
CAS:103890-69-3
LCD62 :
Lacidipine RC 2 ;

(E)-tert-Butyl 4-(3-(dimethylamino)acryloyl)piperidine-1-carboxylate ;
CAS:960201-86-9
ZNB65 :
Zanubrutinib RC 5 ;

(E)-tert-Butyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethan-3-ylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxohept-6-enoate ;
CAS:947262-23-9
RSVC5 :
Rosuvastatin Impurity 25 ;

(E,E)-N,N'-bis[(5-Nitrofuran-2-yl)methylidene]hydrazine ;
CAS:736-53-8
NRX04 :
Nifuroxazide EP Impurity D ; 5-Nitrofurfural Azine ; Nifuratel Impurity F ;

(E/Z)-1-Chloro-6,6-dimethylhept-2-en-4-yne ;
CAS:126764-17-8
TBN76 :
Terbinafine RC 16 ;

(E/Z)-4-Amino-N,N,N-trimethyl-4-oxobut-2-en-1-aminium chloride ;
CAS:857162-57-3
LCT04 :
Levocarnitine EP Impurity D ;

(E/Z)-Methyl 2-(4-fluorobenzylidene)-4-methyl-3-oxopentanoate ;
CAS:122549-26-2
RSVD6 :
Rosuvastatin Impurity 36 ;

(E/Z)-Methyl 2-hydroxy-5-((4-hydroxyphenyl)diazenyl)benzoate ;
OSL61 :
Olsalazine RC 1 ; 3-Descarboxy Olsalazine Methyl Ester ;

(Ethoxycarbonyl)phosphonic acid ;
CAS:55920-71-3
FSC01A :
Foscarnet EP Impurity A (Acid) ;

(EZ)-1-Methylamino-1-methylthio-2-nitroethene ;
CAS:61832-41-5
NZT02 :
Nizatidine EP Impurity B ; Ranitidine EP Impurity K ; Nizatidine MMN Intermediate ;

(EZ)-11+¦,20-Dihydroxy-6+¦-methylpregna-1,4,17(20)-triene-3,21-dione ;
CAS:150899-33-5 & 1338549-02-2
MPS04 :
Methylprednisolone EP Impurity D ; Methylprednisolone Acetate EP Impurity D ;

(EZ)-N1,N1GÇ¦-[Thiazole-2,4-diylbis(methylenesulphanediylethylene)] bis(NGÇ¦-methyl-2-nitroethene-1,1-diamine) ;
CAS:1193434-62-6
NZT06 :
Nizatidine EP Impurity F ;

(GêÆ)-(2S)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide ;
CAS:27262-40-4
RPV02B :
Ropivacaine EP Impurity B (Base) ; Ropivacaine N-Despropyl Analog ;

(GêÆ)-(S)-N-(2,6-Dimethylphenyl)-1(1-methylethyl)piperidine-2-carboxamide ;
CAS:265120-58-9
RPV05B :
Ropivacaine EP Impurity E ; Ropivacaine N-Isopropyl Analog ;

(GêÆ)-(S)-N-(2,6-Dimethylphenyl)-1-ethylpiperidine-2-carboxamide ;
CAS:98626-59-6
RPV04B :
Ropivacaine EP Impurity D ; Ropivacaine N-Ethyl Analog ;

(GêÆ)-(S)-N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide ;
CAS:24358-84-7
RPV03B :
Ropivacaine EP Impurity C (Base) ; Ropivacaine BP Impurity C ; N-Methyl Ropivacaine ; (S)-Mepivacaine ;

(GêÆ)-(S)-N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide HCl ;
CAS:34333-71-6
RPV03H :
Ropivacaine EP Impurity C (HCl) ; Ropivacaine BP Impurity C ; N-Methyl Ropivacaine HCl ; (S)-Mepivacaine HCl ;

(GêÆ)-(S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide ;
CAS:84057-95-4
RPV00B :
Ropivacaine (Base) ;

(GêÆ)-(S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate ;
CAS:132112-35-7
RPV00H :
Ropivacaine (HCl Monohydrate) ; Ropivacaine Hydrochloride Monohydrate ;

(Naphthalen-1-yl)acetic acid ;
CAS:86-87-3
NPZ02 :
Naphazoline EP Impurity B ;

(Naphthalen-1-yl)acetonitrile ;
CAS:132-75-2
NPZ03 :
Naphazoline EP Impurity C ;

(Pyridin-3-yl)methanamine ;
CAS:3731-52-0
PCD04 :
Picotamide EP Impurity D ;

(R)-((1S,3R,7S,8S)-8-(2-((2R,4R)-4-(tert-Butyldimethylsilyloxy)-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate ;
CAS:82978-03-8
LVS61 :
Lovastatin Impurity 1 ;

(R)-((2R,5S)-5-(4-Aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol ;
CAS:1295539-30-8
VBG64 :
Vibegron RC 4 ;

(R)-((R)-5-(4-Nitrobenzyl)-3,4-dihydro-2H-pyrrol-2-yl)(phenyl)methanol ;
CAS:1628836-09-8
VBG65 :
Vibegron RC 5 ;

(R)-(-)-1-[2-[(4-Chlorophenyl)-phenyl-methoxy]ethyl]piperidine ;
LCP00B :
Levocloperastine (Base) ; Levocloperastine ;

(R)-(-)-1-[2-[(4-Chlorophenyl)-phenyl-methoxy]ethyl]piperidine hydrochloride ;
LCP00H :
Levocloperastine (HCl) ; Levocloperastine Hydrochloride ;

(R)-(-)-1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]piperidine fendizoate ; 2-[(6-Hydroxy-[1,1'-biphenyl]-3-yl)carbonyl]benzoic acid salt with (-)-1-[2-[(R)-(4-chlorophenyl)phenylmethoxy]ethyl]piperidine ;
CAS:220329-19-1
LCP00F :
Levocloperastine (Fendizoate) ; (R)-Cloperastine Fendizoate ; (L)-Cloperastine Fendizoate ;

(R)-(-)-3-(Aminomethyl)-5-methylhexanoic acid ;
CAS:148553-51-9
PRG02 :
Pregabalin EP Impurity B ; Pregabalin USP RC A ; Pregabalin (R)-Isomer ; Pregabalin Enantiomer ;

(R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid ;
CAS:181289-33-8
PRG36 :
Pregabalin 3-Carbamoylmethyl Impurity ; Isobutylglutarmonoamide ;

(R)-(-)-Mandelic Acid ; (2R)-(-)-Hydroxybenzeneacetic acid ;
CAS:611-71-2
STL05 :
Sertraline EP Impurity E ; D-Mandelic Acid ;

(R)-(-)-N-(2,3-Epoxypropyl)phthalimide ;
CAS:181140-34-1
RVR48 :
Rivaroxaban Epoxypropyl Phthalimide Impurity ;

(R)-(1-(6-(Isopropoxycarbonyl)-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid ;
CAS:1391053-20-5
TNF65
Tenofovir Isopropyl Carbamate ;

(R)-(2,3-Dihydro-1H-inden-1-yl)(prop-2-yn-1-yl)sulfamic acid ;
RSG56 :
Rasagiline N-Sulfate ;

(R)-(4-Chlorophenyl)(phenyl)methanol ; (R)-4-Chlorobenzhydrol ;
CAS:123535-85-3
LCP56R :
Levocloperastine CBZ (R)-Isomer ;

(R)-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamic acid ;
SGT37 :
Sitagliptin N-Formic Acid Adduct ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol ;
CAS:130-95-0
QNN00B :
Quinine (Base) ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol ;
CAS:130-95-0
QND01 :
Quinidine EP Impurity A ; Quinine ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol hydrochloride ;
CAS:130-89-2
QNN00H :
Quinine (HCl Anhydrous) ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol hydrochloride dihydrate ;
CAS:6119-47-7
QNN00D :
Quinine (HCl Dihydrate) ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](quinolin-4-yl)methanol ;
CAS:485-71-2
QNN02B :
Quinine EP Impurity B (Base) ; Cinchonidine ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](quinolin-4-yl)methanol dihydrochloride ;
CAS:524-54-9 & 24302-67-8
QNN02X :
Quinine EP Impurity B (2HCl) ; Cinchonidine Dihydrochloride ;

(R)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](quinolin-4-yl)methanol monohydrochloride ;
CAS:524-57-2
QNN02H :
Quinine EP Impurity B (HCl) ; Cinchonidine Monohydrochloride ;

(R)-[(2S,4S,5R)-5-Ethyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol ;
CAS:522-66-7
QNN03 :
Quinine EP Impurity C ; Dihydroquinine ;

(R)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol ;
CAS:51744-84-4
MFQ51B :
Mefloquine (R,R)-Isomer (Base) ; (R,R)-Mefloquine ; (-)-Threo-Mefloquine ;

(R)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol HCl ;
CAS:58560-52-4
MFQ51H :
Mefloquine (R,R)-Isomer (HCl) ; (R,R)-Mefloquine HCl ;

(R)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2S)-piperidin-2-yl]methanol ;
CAS:51688-68-7
MFQ52B :
Mefloquine (R,S)-Isomer (Base) ; (R,S)-Mefloquine ; (+)-Mefloquine ;

(R)-[2-[4-(4-Chlorophenyl)phenylmethyl]-1-oxido-1-piperazinyl]ethoxy]acetic acid ;
CAS:442863-80-1
LCZ58B :
Levocetirizine N-Oxide ; Cetirizine N-Oxide (R)-Isomer ;

(R)-1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ;
CAS:61364-37-2
MTZ53 :
Mirtazapine (R)-Isomer ;

(R)-1-((R)-1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine 1-oxide ;
CAS:2031255-25-9
IBT74 :
Ibrutinib Impurity 24 ;

(R)-1-([1,1'-Biphenyl]-4-yl)-3-(benzyloxy)propan-2-amine ;
CAS:2024588-67-6
SCT68 :
Sacubitril AHU-76 (Base) ;

(R)-1-([1,1'-Biphenyl]-4-yl)-3-(benzyloxy)propan-2-amine HCl ;
CAS:2024588-68-7
SCT67 :
Sacubitril AHU-76 (HCl) ;

(R)-1-(1-([1,1'-Biphenyl]-4-yl)-3-chloropropan-2-yl)pyrrolidine-2,5-dione ;
CAS:1573000-36-8
SCT80 :
Sacubitril RC 10 ;

(R)-1-(1-Acryloylpiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one ;
CAS:2031255-24-8
IBT44 :
Ibrutinib 4-Oxo Impurity ;

(R)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide ;
CAS:1152311-62-0
TZC00 :
Tezacaftor ; Tezacaftor R-Isomer ;

(R)-1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one ;
CAS:107381-31-7
PRP56 :
Propafenone (R)-Isomer ;

(R)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide ;
CAS:1211679-98-9
VDG58 :
Vildagliptin Chloroacetyl Amide (R)-Isomer ;

(R)-1-(3-(4-(2-Carboxyethyl)amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one ;
IBT95 :
Ibrutinib N-Carboxyethyl-áImpurity ;

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one ;
CAS:1288338-96-4
IBT55 :
Ibrutinib Impurity 5 ;

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-methoxypropan-1-one ;
CAS:2031255-26-0
IBT73 :
Ibrutinib Impurity 23 ;

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)butan-1-one ;
CAS:1839099-23-8
IBT75 :
Ibrutinib Impurity 25 ;

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethanone ;
CAS:1288338-95-3
IBT46 :
Ibrutinib N-Acetyl Analog ;

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one ;
CAS:1839099-22-7
IBT43 :
Ibrutinib N-Propionyl Analog ;

(R)-1-(3-(Benzyloxy)propyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide ;
CAS:175870-40-3
SLD85 :
Silodosin RC 15 ; Benzyl Silodosin ;

(R)-1-(3-Hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl) (2-(2-(2,2,2-trifluoroethyl)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide ;
CAS:1453221-45-8
SLD54 :
Silodosin Dimer Analog (USP) ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy) ethylamino)propyl)-1H-indole-7-carboxamide ;
CAS:175870-21-0
SLD52 :
Silodosin Dehydro Impurity ; Silodosin Indole Analog (USP) ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy) ethylamino)propyl)indoline-7-carbonitrile ;
CAS:885340-13-6
SLD55B :
Silodosin Nitrile Impurity (Base) ; Cyanosilodosin ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)-N-nitroso-ethylamino) propyl)indoline-7-carboxamide ;
SLD48 :
Silodosin N-Nitroso Impurity ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino) propyl)indoline-7-carboxamide ;
CAS:160970-54-7
SLD00 :
Silodosin ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino) propyl)indoline-7-carboxamide N-oxide ;
CAS:2361272-05-9
SLD56 :
Silodosin N-Oxide ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carbonitrile hydrochloride ;
CAS:1889255-72-4
SLD55H :
Silodosin Nitrile Impurity (HCl) ; Cyanosilodosin HCl (USP) ;

(R)-1-(3-Hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxylic acid ;
CAS:1431373-77-1
SLD82 :
Silodosin RC 12 ;

(R)-1-(4-(3-Methylthiophen-2-yl)-4-(thiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid hydrochloride ;
CAS:748741-38-0 (HCl) 148407-65-2 (Base)
TGB51 :
Tiagabine Desmethyl ;

(R)-1-(4-Nitrophenyl)ethanamine;
CAS:22038-87-5
TMS70 :
Tamsulosin RC 10 ;

(R)-1-(5-Amino-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-1-yl)-3-(benzyloxy)propan-2-ol ;
CAS:1294504-67-8
TZC61 :
Tezacaftor RC 1 ;

(R)-1-(6-Amino-9H-purin-9-yl)propan-2-ol ;
CAS:14047-28-0
TNF60B :
Tenofovir (R)-Propanol Impurity ;

(R)-1-(9H-Purin-6-ylamino)propan-2-ol ;
CAS:1244022-52-3
TNFA2 :
Tenofovir RC 12 ;

(R)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile ;
CAS:565452-98-4
VDG57 :
Vildagliptin Chloroacetyl Nitrile (R)-Isomer ;

(R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine ;
CAS:300543-56-0
LCZ51B :
Levocetirizine Chlorobenzhydryl Piperazine (USP) ;

(R)-1-[3-(Acetyloxy)propyl]-2,3-dihydro-5-[2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy] ethyl]amino]propyl]-1H-Indole-7-carboxamide ;
CAS:160970-86-5
SLD57 :
Silodosin O-Acetyl Impurity ;

(R)-1-[4,4-Bis(3-Methyl-2-thienyl)-3,4-dihydroxybutyl]-3-piperidinecarboxylic acid ;
TGB52 :
Tiagabine Dihydroxy Impurity ;

(R)-1-[4,4-Bis(3-Methyl-2-thienyl)-3-oxobutyl]-3-piperidinecarboxylic acid ;
CAS:161014-55-7
TGB53B :
Tiagabine Keto Impurity (Base) ;

(R)-1-[4,4-Bis(3-Methyl-2-thienyl)-3-oxobutyl]-3-piperidinecarboxylic acid 4-methylbenzenesulfonate ;
CAS:161014-56-8
TGB53T :
Tiagabine Keto Impurity (Tosylate) ;

(R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline ;
CAS:180272-45-1
SLF65B :
Solifenacin Impurity 5 ;

(R)-1-Phenylethanamine ;
CAS:3886-69-9
PRG05B :
Pregabalin EP Impurity E (Base) ; Levetiracetam EP Impurity E ; Pregabalin Impurity 32 ;

(R)-1-Phenylethanamine ;
CAS:3886-69-9
LET05B :
Levetiracetam EP Impurity E ; Pregabalin EP Impurity E ; Pregabalin Impurity 32 ;

(R)-1-Phenylethanamine HCl ;
CAS:10277-86-8
PRG05H :
Pregabalin EP Impurity E (HCl) ; Levetiracetam EP Impurity E (HCl) ; Pregabalin Impurity 32 (HCl) ;

(R)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid mesylate ;
CAS:677004-96-5
PZF50M :
Pazufloxacin Mesylate Enantiomer ; R-Pazufloxacin Mesylate ;

(R)-10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro [1,2,4] triazolo [3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione ;
CAS:2088771-61-1 (10R)
SGT42 :
Sitagliptin FP Impurity B ; Sitagliptin Triazecine Analog ;

(R)-10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-9,10-dihydro-5H-[1,2,4]triazolo[3',4':3,4]pyrazino[1,2-a]pyrimidin-8(6H)-one ;
SGT48B :
Sitagliptin M2 Dehydro R-Isomer ;

(R)-2,4-Dihydroxy-3,3-dimethylbutanoic acid ;
CAS:1112-33-0
PTT02A :
Pantothenate EP Impurity B (Acid) ; Pantoic Acid ;

(R)-2-((1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1Hpurin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid ;
CAS:2074688-81-4
LGT07 :
Linagliptin EP Impurity G ;

(R)-2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride ;
CAS:56287-63-9
VLX51H :
Viloxazine (R)-Isomer HCl ;

(R)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione ;
CAS:1424944-35-3
RVR97 :
Rivaroxaban RC 37 ;

(R)-2-((4-(2-Methoxyethyl)phenoxy)methyl)oxirane ;
CAS:133397-54-3
MTP63 :
Metoprolol RC 3 ;

(R)-2-((6-(3-((3-(2-Cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile ;
TLG74 :
Trelagliptin RC 14 ;

(R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide ;
CAS:1938080-44-4
TLG66 :
Trelagliptin RC 6 ;

(R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile ;
CAS:865759-25-7
TLG00 :
Trelagliptin ;

(R)-2-((E)-3-(2-((E)-3,4-Dihydroxystyryl)-3,4-dihydroxyphenyl)acryloyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid ;
CAS:96574-01-5
SVN01
Salvianolic Acid A ;

(R)-2-((Naphthalen-1-yloxy)methyl)oxirane ;
CAS:56715-28-7
NFP65 :
Naftopidil RC 5 ;

(R)-2-((R)-(2-Ethoxyphenoxy)(phenyl)methyl)oxirane ;
CAS:98769-72-3
RBX67 :
Reboxetine RC 7 ;

(R)-2-((R)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-ylamino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide dihydrobromide ;
NGT51H :
Nirogacestat (R,R)-Isomer (Dihydrobromide) ;

(R)-2-((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-ylamino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide dihydrobromide ;
NGT52H :
Nirogacestat (R,S)-Isomer (Dihydrobromide) ;

(R)-2-(1-([1,1'-Biphenyl]-4-yl)-3-(benzyloxy)propan-2-yl)isoindoline-1,3-dione ;
CAS:2036308-56-0
SCT66 :
Sacubitril AHU-74B ;

(R)-2-(2,3-Dihydroxypropyl)isoindoline-1,3-dione ;
CAS:186348-58-3
RVRA9
Rivaroxaban RC 49 ;

(R)-2-(2,5-Difluorophenyl)pyrrolidine ;
CAS:1218935-59-1
LTT56B :
Larotrectinib Pyrrolidine Impurity ;

(R)-2-(2,5-Difluorophenyl)pyrrolidine HCl ;
CAS:1218935-60-4
LTT56H :
Larotrectinib Pyrrolidine Impurity (HCl) ;

(R)-2-(2,6-Dioxopiperidin-3-yl)isoindoline-1,3-dione ;
CAS:2614-06-04 00:00:00
TLD51 :
Thalidomide (R)-Isomer ;

(R)-2-(2-((R)-2-(2-((3R,5S)-1-((S)-1-((S)-2-((R)-2-Amino-5-guanidinopentanamido)-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)-3-hydroxypyrrolidine-5-carboxamido)acetamido)-3-(thiophen-2-yl)propanamido)-3-hydroxypropanoyl)-1,2,3,4-tetrahydro
ITB63T :
Icatibant RC 3 (TFA Salt) ;

(R)-2-(2-(1-Ethyl-2,3-dioxopiperazine-4-carboxamido)-2-phenylacetamido)acetic acid ;
CAS:2170771-47-6
PPR10 :
Piperacillin EP Impurity J ; Piperacillin Impurity 2 ;

(R)-2-(2-(4-(3-(2-Chlorothiophene-5-carboxamido)-2-hydroxypropylamino)phenylamino)ethoxy)acetic acid ;
RVR80 :
Rivaroxaban RC 20 ;

(R)-2-(2-(Benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid ;
CAS:2271299-08-0
LGS50A :
Lifitegrast (R)-Isomer ;

(R)-2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide ;
CAS:909779-33-5
LCZ53B :
Levocetirizine EP Impurity J (Base) ; Levocetirizine Amide (Base) ;

(R)-2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide dihydrochloride ;
LCZ53H :
Levocetirizine EP Impurity J (2HCl) ; Levocetirizine Amide (2HCl) ;

(R)-2-(2-Aminothiazol-4-yl)-N-(3-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)acetamide ;
CAS:1684452-80-9
MRB57B :
Mirabegron ortho-Isomer ;

(R)-2-(2-Aminothiazol-4-yl)-N-(3-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)acetamide ;
CAS:1684452-81-0
MRB56B :
Mirabegron meta-Isomer ;

(R)-2-(2-Aminothiazol-4-yl)-N-(4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)amino)-2-oxoethyl)thiazol-2-yl)acetamide ;
CAS:2489747-26-2
MRB04B :
Mirabegron EP Impurity D (Base) ; Mirabegron Diamide 2 ;

(R)-2-(2-Aminothiazol-4-yl)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-N-(2-hydroxy-2-phenylethyl)acetamide ;
MRB71B :
Mirabegron Diamide 1 ;

(R)-2-(2-Ethoxyphenoxy)-N-(1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl)acetamide ;
CAS:133261-17-3
TMS62 :
Tamsulosin RC 2 ; Tamsulosin Amide ;

(R)-2-(2-Hydroxy-3-(nitroso(4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione ; (R)-N-(3-(1,3-Dioxo isoindolin-2-yl)-2-hydroxypropyl)-N-(4-(3-oxo morpholino) phenyl) nitrous amide ;
RVRA6
Rivaroxaban RC 46 ;

(R)-2-(2-Oxopyrrolidin-1-yl)butanoic acid ;
CAS:103833-72-3
LET57 :
Levetiracetam Impurity 7 ; Levetiracetam Acid R-Isomer ;

(R)-2-(3-Amino-1-phenylpropyl)-4-methylphenol ;
CAS:1203453-90-0
TTR67 :
Tolterodine Impurity 7 ;

(R)-2-(4-(3-Fluorobenzyloxy)benzylamino)propanamide ;
CAS:174756-44-6
SFN50 :
Safinamide (R)-Isomer ; Safinamide Enantiomer (USP) ;

(R)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide ;
CAS:1038915-58-0
NRP54B :
Niraparib R-Isomer (Base) ; Niraparib Enantiomer ;

(R)-2-(4-Aminophenethylamino)-1-phenylethanol ;
CAS:391901-45-4
MRB02B :
Mirabegron EP Impurity B (Base) ; Mirabegron USP RC A (Base) ; Mirabegron Des-ATAA Impurity (Base) ;

(R)-2-(4-Aminophenethylamino)-1-phenylethanol HCl ;
CAS:521284-22-0
MRB02H :
Mirabegron EP Impurity B (HCl) ; Mirabegron USP RC A (HCl) ; Mirabegron Des-ATAA Impurity (HCl) ;

(R)-2-(4-Nitrophenethylamino)-1-phenylethanol ;
CAS:223673-34-5
MRB06B :
Mirabegron EP Impurity F (Base) ; Mirabegron RC 2 (Base) ;

(R)-2-(4-Nitrophenethylamino)-1-phenylethanol hydrochloride ;
CAS:521284-21-9
MRB06H :
Mirabegron EP Impurity F (HCl) ; Mirabegron RC 2 (HCl) ;

(R)-2-(4-Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide 4-methylbenzenesulfonate ;
CAS:2307785-07-3
NRP54T :
Niraparib R-Isomer (Tosylate) ; Niraparib Enantiomer Tosylate ;

(R)-2-(8-Fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid ;
CAS:917389-37-8
LTM50 :
Letermovir (R)-Isomer ;

(R)-2-(Acetylamino)-3-methoxy-N-methyl-N-(phenylmethyl)-propanamide ;
LSM03 :
Lacosamide EP Impurity C ; Lacosamide N-Methyl Impurity ;

(R)-2-(Benzyloxycarbonyl)-3-methoxypropanoic acid ;
CAS:86096-35-7
LSM64 :
Lacosamide Impurity 4 ;

(R)-2-(Propylamino)-N-o-tolylpropanamide ;
CAS:14289-32-8
PLC51B :
Prilocaine R-Isomer (Base) ;

(R)-2-(Propylamino)-N-o-tolylpropanamide HCl ;
PLC51H :
Prilocaine R-Isomer (HCl) ;

(R)-2-[4-(2-Methylpropyl)phenyl]propanoic acid ;
CAS:51146-57-7
IBP52 :
Ibuprofen (R)-Isomer ; l-(-)-Ibuprofen;

(R)-2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]acetic acid ;
CAS:942193-17-1
LCZ52B :
Levocetirizine Acetic Acid (Base) ;

(R)-2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]acetic acid hydrochloride ;
CAS:942132-30-1
LCZ52H :
Levocetirizine Acetic Acid (HCl) ;

(R)-2-Acetamido-3-methoxypropanoic acid ;
CAS:196601-67-9
LSM61 :
Lacosamide Impurity 1 ;

(R)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid ;
MTD62 :
Methyldopa EP Impurity B R-Isomer ;

(R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole ;
CAS:104632-28-2
PMP04B :
Pramipexole EP Impurity D (Base) ; Pramipexole USP RC D ; Pramipexole R-Isomer ; Dexpramipexole ;

(R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride ;
CAS:104632-27-1
PMP04H :
Pramipexole EP Impurity D (2HCl) ; Pramipexole USP RC D ; Pramipexole Dihydrochloride R-Isomer ; Dexpramipexole Dihydrochloride;

(R)-2-Amino-4,5,6,7-tetrahydro-6-aminobenzothiazole ;
CAS:106092-11-9
PMP46B :
Pramipexole N6-Despropyl (R)-Isomer ; Pramipexole (6R)-Amino Impurity ;

(R)-2-Aminobutanamide ;
CAS:104652-77-9
LET53B :
Levetiracetam Impurity 3 (Base) ;

(R)-2-Aminobutanamide hydrochloride ;
CAS:103765-03-3
LET53H :
Levetiracetam Impurity 3 (HCl) ;

(R)-2-Aminobutanoic acid ; D-2-Amino-butyric acid ;
CAS:2623-91-8
LET51B :
Levetiracetam Impurity 1 (Base) ;

(R)-2-Aminobutanoic acid hydrochloride ; D-2-Amino-butyric acid hydrochloride ;
CAS:67607-42-5
LET51H :
Levetiracetam Impurity 1 (HCl) ;

(R)-2-Chloro-N-(1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl)acetamide ;
CAS:855298-56-5
TMS61 :
Tamsulosin RC 1 ;

(R)-2-Hydroxy-3-(2-methoxyphenoxy)propyl carbamate ;
CAS:145841-69-6
MTC50 :
Methocarbamol (R)-Isomer ;

(R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol ;
PNP26B :
Phenylephrine USP RC F (Base) ;

(R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate ;
CAS:1007885-60-0
PNP26H :
Phenylephrine USP RC F (HCl) ;

(R)-2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidine-5-carbaldehyde ;
CAS:1160170-03-5
RVR95 :
Rivaroxaban RC 35 ;

(R)-2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidine-5-carboxylic acid ;
CAS:1160170-07-9
RVR96 :
Rivaroxaban RC 36 ;

(R)-3-(((S)-2-Hydroxy-1-phenylethyl)amino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one ;
CAS:1459759-18-2
SGT38 :
Sitagliptin N-Phenylethanol Adduct ;

(R)-3-((2S,3S)-3-(3-(Dibenzylamino)phenyl)-2-(2-methyl-1,3-dioxolan-2-yl)pentanoyl)-4-phenyloxazolidin-2-one ;
CAS:188559-29-7
TNV61 :
Tipranavir RC 1 ;

(R)-3-((2S,5R)-2-((S)-1-(3-(Dibenzylamino)phenyl)propyl)-5-hydroxy-3-oxo-5-phenethyloct-6-ynoyl)-4-phenyloxazolidin-2-one ;
CAS:188559-22-0
TNV63 :
Tipranavir RC 3 ;

(R)-3-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanenitrile ; (3+¦,5+¦,7+¦)-3,7-Dihydroxy-24-norcholane-23-nitrile ;
CAS:118316-12-4
UDC53 :
Ursodeoxycholic Acid RC 3 ;

(R)-3-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoic acid ;
CAS:99697-24-2
UDC59 :
Ursodeoxycholic Acid RC 9 ;

(R)-3-((9Z,12Z)-Octadeca-9,12-dienoyloxy)-4-(trimethylammonio)butanoate ;
CAS:36816-10-1
LCT67 :
Levocarnitine RC 7 ; Octadecadienoyl L-Carnitine ; cis,cis-9,12-Octadecadienoyl L-Carnitine ;

(R)-3-((R)-1-(3-(Dibenzylamino)phenyl)propyl)-4-hydroxy-6-phenethyl-6-(prop-1-ynyl)-5,6-dihydropyran-2-one ;
CAS:188559-25-3
TNV62 :
Tipranavir RC 2 ;

(R)-3-((R)-3-Hydroxyoctadecanoyloxy)-4-(trimethylammonio)butanoate ;
CAS:1469901-05-0
LCT66 :
Levocarnitine RC 6 ; 3-Hydroxy Octadecanoyl L-Carnitine ;

(R)-3-((R)-3-Hydroxytetradecanoyloxy)-4-(trimethylammonio)butanoate ;
CAS:1469901-02-7
LCT70 :
Levocarnitine RC 10 ; (3R)-3-Hydroxytetradecanoyl L-Carnitine ;

(R)-3-((R,Z)-3-Hydroxyoctadec-9-enoyloxy)-4-(trimethylammonio)butanoate ;
LCT65 :
Levocarnitine RC 5 ; 3-Hydroxy Octadecenoyl L-Carnitine ;

(R)-3-(1-(1-Acryloylpiperidin-3-yl)-4-imino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-5(4H)-yl)propanoic Acid ;
IBT94 :
Ibrutinib N-Carboxyethyl Imine Impurity ;

(R)-3-(1-(Dimethylamino)ethyl)phenol ;
CAS:851086-95-8
RVS66 :
Rivastigmine RC 6 ;

(R)-3-(2-(4-Benzhydrylpiperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate ;
CAS:133082-19-6
MDP51B :
Manidipine (R)-Isomer (Base) ;

(R)-3-(2-(4-Benzhydrylpiperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate HCl ;
MDP51H :
Manidipine (R)-Isomer (HCl) ;

(R)-3-(2-Hydroxy-5-methylphenyl)-3-phenylpropanoic acid sodium salt ;
TTR31N :
Tolterodine Propanoic Acid R-Isomer Sodium Salt ;

(R)-3-(3-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)PIPERIDIN-1-YL)-3-OXOPROPYL ACRYLATE
IBT61 :
Ibrutinib Impurity 11 ; N-Desacryloyl N-(3-Acryloyl-propanoyl) Ibrutinib ;

(R)-3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione ;
CAS:874946-00-6
LLM40 :
Lenalidomide (R)-Isomer ;

(R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one ;
CAS:444335-16-4
TDZ59 :
Tedizolid Impurity 9 ;

(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ;
CAS:1022150-12-4
IBT96B :
Ibrutinib N-Desacryloyl Impurity (Base) ; Ibrutinib M23 ;

(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride ;
CAS:1701403-10-2
IBT96H :
Ibrutinib N-Desacryloyl Impurity (2HCl) ; Ibrutinib M23 (2HCl) ;

(R)-3-(5-(2-(Bis(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-7-cyanoindolin-1-yl)propyl benzoate ;
CAS:885340-14-7
SLD81 :
Silodosin RC 11 ;

(R)-3-(7-(Aminomethyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indolin-1-yl)propan-1-ol ;
SLD64 :
Silodosin 7-Aminomethyl ;

(R)-3-(7-Carbamoyl-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino) propyl)indolin-1-yl)propanoic acid ;
CAS:1357252-79-9
SLD51 :
Silodosin Carboxylic Acid Impurity ;

(R)-3-(7-Cyano-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indolin-1-yl)propyl 4-methylbenzoate ;
CAS:1638212-09-5
SLD80 :
Silodosin RC 10 ;

(R)-3-(Aminomethyl)-5-methylhex-4-enoic acid ;
CAS:1101167-84-3
PRG43B :
Pregabalin 4,5-Dehydro (R)-Isomer ;

(R)-3-(Aminomethyl)-5-methylhex-5-enoic acid ;
PRG57B :
Pregabalin 5,6-Dehydro (R)-Isomer (Base) ; (R)-5,6-Dehydro Pregabalin ; Pregabalin 5-Eliminate (R)-Isomer ;

(R)-3-(Boc-amino)piperidine ;
CAS:309956-78-3
LGT71 :
Linagliptin RC 1 ;

(R)-3-(Docosanoyloxy)-4-(trimethylammonio)butanoate ;
LCT63B :
Levocarnitine RC 3 (Base) ; Docosanoyl L-Carnitine ;

(R)-3-(Docosanoyloxy)-4-(trimethylammonio)butanoate hydrochloride ;
CAS:2133456-10-5
LCT63H :
Levocarnitine RC 3 (HCl) ; Docosanoyl L-Carnitine HCl ;

(R)-3-(Methylamino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one ;
SGT31B :
Sitagliptin N-Methyl (Base) ;

(R)-3-(Methylamino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one TFA salt ;
SGT31T :
Sitagliptin N-Methyl (TFA Salt) ;

(R)-3-(tert-Butoxycarbonyl)-4-(2,4,5-trifluorophenyl)butanoic acid ;
CAS:486460-00-8
SGT59 :
Sitagliptin N-BOC Carboxylic Acid ;

(R)-3-(Tetracosanoyloxy)-4-(trimethylammonio)butanoate ;
LCT62B :
Levocarnitine RC 2 (Base) ; Tetracosanoyl L-Carnitine ;

(R)-3-(Tetracosanoyloxy)-4-(trimethylammonio)butanoate HCl ;
CAS:123359-35-3
LCT62H :
Levocarnitine RC 2 (HCl) ; Tetracosanoyl L-Carnitine HCl ;

(R)-3-[3-[[(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl]methylamino] propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one hydrochloride ;
CAS:148849-68-7
IVB60H :
Ivabradine R-Isomer HCl ; Ivabradine Enantiomer HCl ;

(R)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,3,6-trifluorophenyl)butan-1-one ;
SGT57B :
Sitagliptin 2,3,6-Trifluorophenyl Analog ; 4-Desfluoro 2-Fluoro Sitagliptin ;

(R)-3-Amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide ;
CAS:2072867-07-1
SGT50B :
Sitagliptin Dimer ;

(R)-3-Carboxy-N,N,N-trimethyl-2-(tetradecanoyloxy)propan-1-aminium chloride ;
CAS:173686-73-2
LCT72 :
Levocarnitine RC 12 ; Myristoyl-L-carnitine Chloride ;

(R)-3-Hydroxy-4,4-dimethyl-dihydrofuran-2(3H)-one ;
CAS:599-04-2
PTT03 :
Pantothenate EP Impurity C ; Pantolactone ;

(R)-4,6-Dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one ;
CAS:63740-75-0
WFR70 :
Warfarin RC10 ; (R)-6-Hydroxy Warfarin ;

(R)-4,7-Dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one ;
CAS:63740-76-1
WFR76 :
Warfarin RC16

(R)-4,8-Dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one ;
CAS:63740-77-2
WFR80 :
Warfarin RC20

(R)-4-((1R,3S,5R,8S,9S,10S,13R,14S,17R)-1,3-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:89238-74-4
LCX66 :
Lithocholic Acid RC 6 ;

(R)-4-((1R,3S,7S,8S,9S,10S,13R,14S,17R)-1,3,7-Trihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:108179-87-9
UDC64 :
Ursodeoxycholic Acid RC 14 ;

(R)-4-((3R,5R,6R,8S,9S,10R,13R,14S,17R)-3,6-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:668-49-5
LCX65 :
Lithocholic Acid RC 5 ;

(R)-4-((3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:2393-61-5
LCX64 :
Lithocholic Acid RC 4 ;

(R)-4-((3R,5R,7S,8S,9S,10R,13R,14S,17R,Z)-6-Ethylidene-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ; (3+¦,5+¦,6Z,7+¦)-6-Ethylidene-3,7-dihydroxy-cholan-24-oic acid ;
CAS:1885104-64-2
OBT53 :
Obeticholic Acid 6-Ethylidene ;

(R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:434-13-9
LCX00 :
Lithocholic Acid ; Ursodeoxycholic Acid EP Impurity C ; Chenodeoxycholic Acid EP Impurity C ; 7-Deoxy Ursodeoxycholic Acid ; 7-Deoxy Chenodeoxycholic Acid ;

(R)-4-((3R,5R,8S,9S,10R,13R,14S,17R,Z)-6-Ethylidene-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:915038-24-3
OBT61 :
Obeticholic Acid Impurity 1 ;

(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-Ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:459789-99-2
OBT00 :
Obeticholic Acid ;

(R)-4-((3R,5S,6R,7S,8S,9S,10S,13R,14S,17R)-6-Ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:865244-30-0
OBT62 :
Obeticholic Acid Impurity 2 ;

(R)-4-((3R,5S,6S,8S,9S,10S,13R,14S,17R)-6-Ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ; (3+¦,5+¦,6+¦,7+¦)-6-Ethyl-3,7-dihydroxycholan-24-oic Acid; (3+¦,5+¦,6+¦,7+¦)-6-Ethyl-3,7-dihydroxy-cholan-
CAS:915038-27-6
OBT52 :
Obeticholic Acid 6-Epimer ;

(R)-4-((3R,5S,6S,8S,9S,10S,13R,14S,17R)-6-Ethyl-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:915038-25-4
OBT54 :
Obeticholic Acid 6+¦-Ethyl 7-Keto ;

(R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-7,12-dioxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:517-33-9
LCX62 :
Lithocholic Acid RC 2 ;

(R)-4-((3R,6S,7S,8S,9S,10S,13R,14S,17R)-6-Ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:1708092-13-0
UDC55 :
Ursodeoxycholic Acid RC 5 ;

(R)-4-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-12-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:81873-91-8
UDC58 :
Ursodeoxycholic Acid RC 8 ; Ursodeoxycholic Acid 12-Keto ;

(R)-4-((3S,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:1534-35-6
LCX67 :
Lithocholic Acid RC 7 ;

(R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:5255-17-4
LCX63 :
Lithocholic Acid RC 3 ;

(R)-4-((4-Chlorophenyl)(phenyl)methoxy)-4-oxobutanoic acid ;
LCP55R :
Levocloperastine CBZS (R)-Isomer ; (R)-4-Chlorobenzhydryl Hemisuccinate ;

(R)-4-((5R,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-3-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid ;
CAS:1553-56-6
LCX73 :
Lithocholic Acid RC 13 ;

(R)-4-((R)-(3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)(hydroxy)methyl)oxazolidin-2-one ;
ZMT67B :
Zolmitriptan Impurity 7 ;

(R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one ;
CAS:139264-24-7
ZMT01B :
Zolmitriptan EP Impurity A ; Zolmitriptan R-Isomer ;

(R)-4-(1-(3-(2-Cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-ylamino)-4-oxobutanoic acid ;
CAS:2087874-92-6
TLG73 :
Trelagliptin RC 13 ;

(R)-4-(1-Hydroxy-2-(methylamino)ethyl)benzene-1,2-diol ;
CAS:51-43-4
NRD01B :
Noradrenaline EP Impurity A (Base) ; Adrenaline ; L-(-)-Epinephrine ; Levoepinephrine ; N-Methyl Noradrenaline ; Epinephrine R-Isomer ;

(R)-4-(1-Hydroxy-2-(methylamino)ethyl)benzene-1,2-diol tartrate salt ;
CAS:51-42-3
NRD01T :
Noradrenaline EP Impurity A (Tartrate) ; Adrenaline Tartrate ; Epinephrine Bitartrate ; L-(-)-Epinephrine Tartrate ; Levoepinephrine Tartrate ;

(R)-4-(2-(6-(2-(2,6-Dichlorobenzyloxy)ethoxy)hexylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol ;
CAS:503068-34-6
VLT00B :
Vilanterol (Base) ;

(R)-4-(2-(6-(2-(2,6-Dichlorobenzyloxy)ethoxy)hexylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol 2,2,2-triphenylacetic acid salt ;
CAS:503070-58-4
VLT00T :
Vilanterol (Trifenatate) ;

(R)-4-(2-(6-(2-(2,6-Dichlorobenzyloxy)ethoxy)hexylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol acetate ;
CAS:503068-35-7
VLT00A :
Vilanterol (Acetate) ;

(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol ;
CAS:34391-04-3
LAB00B :
Levalbuterol (Base) ; (R)-Albuterol ; (R)-Salbutamol ; Levosalbutamol ;

(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hydrochloride ;
CAS:50293-90-8
SAB50H :
Salbutamol (R)-Isomer HCl ; (R)-Salbutamol HCl ; Levosalbutamol HCl ; Levalbuterol HCl ; (R)-Albuterol HCl ;

(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hydrochloride ;
CAS:50293-90-8
LAB00H :
Levalbuterol (HCl) ; (R)-Albuterol HCl ; (R)-Salbutamol HCl ; Levosalbutamol HCl ;

(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol sulfate ;
CAS:148563-16-0
LAB00S :
Levalbuterol (Sulfate) ; (R)-Albuterol Sulfate ; (R)-Salbutamol Sulfate ; Levosalbutamol Sulfate ;

(R)-4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol ;
CAS:51-41-2
NRD00B :
Noradrenaline (Base) ; R-Noradrenaline ; L-Norepinephrine ; Levoarterenol ; Adrenaline EP Impurity B ;

(R)-4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol hydrochloride ;
CAS:329-56-6
NRD00H :
Noradrenaline (HCl) ; R-Noradrenaline HCl ; L-Norepinephrine HCl ; Levoarterenol HCl ; Adrenaline EP Impurity B (HCl) ;

(R)-4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol tartrate ;
CAS:51-40-1
NRD00A :
Noradrenaline (Tartrate) ; R-Noradrenaline Tartrate ; L-Norepinephrine Tartrate ; Levoarterenol Tartrate ;

(R)-4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol tartrate monohydrate ;
CAS:108341-18-0
NRD00T :
Noradrenaline (Tartrate Monohydrate) ; R-Noradrenaline Tartrate Monohydrate ; L-Norepinephrine Tartrate Monohydrate ; Levoarterenol Tartrate Monohydrate ;

(R)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol ;
CAS:1932110-67-2
NRD04B :
Noradrenaline EP Impurity D (Base) ; Noradrenaline Methyl Ether ;

(R)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol hydrochloride ;
NRD04H :
Noradrenaline EP Impurity D (HCl) ; Noradrenaline Methyl Ether HCl ;

(R)-4-(2-Aminopropyl)phenol ;
CAS:1518-89-4
SLG61B :
Selegiline RC 1 ;

(R)-4-(2-Chloro-1-hydroxyethyl)benzofuran-3(2H)-one ;
CAS:364380-05-2
TLT77 :
Tasimelteon RC 17 ;

(R)-4-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)pent-4-enoic acid ;
IBT62 :
Ibrutinib Impurity 12 ;

(R)-4-(4-(3-Chloro-2-hydroxypropylamino)phenyl)morpholin-3-one ;
CAS:1252018-10-2
RVR71 :
Rivaroxaban RC 11 ;

(R)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one ;
CAS:1411775-06-8
RVR65B :
Rivaroxaban RC 5 (Base) ; Rivaroxaban Aminomethyl (R)-Isomer ; Rivaroxaban Desthiophene Analog (USP) ;

(R)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one HCl ;
CAS:1429311-47-6
RVR65H :
Rivaroxaban RC 5 (HCl) ; Rivaroxaban Aminomethyl (R)-Isomer (HCl) ; Rivaroxaban Desthiophene Analog (HCl) ;

(R)-4-(4-(5-(Hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one ;
RVR89 :
Rivaroxaban RC 29 ;

(R)-4-(4-Aminobenzyl)oxazolidin-2-one ;
CAS:262857-90-9
ZMT64B :
Zolmitriptan Impurity 4 (Base) ;

(R)-4-(4-Aminobenzyl)oxazolidin-2-one hydrochloride ;
CAS:139264-67-8
ZMT64H :
Zolmitriptan Impurity 4 (HCl) ;

(R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole ;
CAS:119717-21-4
MDT50B :
Medetomidine (R)-Isomer (Base) ; Levomedetomidine ;

(R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole HCl ;
CAS:190000-46-5
MDT50H :
Medetomidine (R)-Isomer (HCl) ; Levomedetomidine HCl ;

(R)-4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione ;
CAS:202271-90-7
PLD60B :
Pomalidomide (R)-Isomer ;

(R)-4-Fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile ;
CAS:1812193-01-3
TLG62 :
Trelagliptin RC 2 ;

(R)-4-Fluoro-2-((3-methyl-6-(3-(1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-ylamino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile ;
TLG75 :
Trelagliptin RC 15 ;

(R)-4-Hydroxy-3-(1-(3-hydroxyphenyl)-3-oxobutyl)-2H-chromen-2-one ;
CAS:124997-75-7
WFR62 :
Warfarin RC2

(R)-4-Hydroxy-3-(1-(4-hydroxyphenyl)-3-oxobutyl)-2H-chromen-2-one ;
CAS:63740-78-3
WFR65 :
Warfarin RC5

(R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-ylsulfamic acid ;
CAS:940002-57-3
SGT55A :
Sitagliptin N-Sulfate (Acid) ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine ;
CAS:486460-32-6
SGT00B :
Sitagliptin (Base) ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine HCl ;
CAS:486459-71-6
SGT00H :
Sitagliptin (HCl Anhydrous) ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine HCl monohydrate ;
CAS:862156-92-1
SGT00X :
Sitagliptin (HCl Monohydrate) ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate ;
CAS:654671-78-0
SGT00Q :
Sitagliptin Phosphate (Anhydrous) ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate monohydrate ;
CAS:654671-77-9
SGT00P :
Sitagliptin Phosphate (Monohydrate) ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4-difluorophenyl)butan-2-amine ;
CAS:945261-48-3
SGT03B :
Sitagliptin EP Impurity C (Base) ; Sitagliptin 5-Desfluoro Impurity ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4-difluorophenyl)butan-2-amine phosphate salt ;
CAS:1345822-86-7
SGT03P :
Sitagliptin EP Impurity C (Phosphate) ; Sitagliptin 5-Desfluoro Phosphate ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,5-difluorophenyl)butan-2-amine ;
CAS:486460-31-5
SGT02B :
Sitagliptin EP Impurity B (Base) ; 4-Desfluoro Sitagliptin ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,5-difluorophenyl)butan-2-amine phosphate salt ;
CAS:1345822-87-8
SGT02P :
Sitagliptin EP Impurity B (Phosphate) ; 4-Desfluoro Sitagliptin Phosphate ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(4,5-difluorophenyl)butan-2-amine ;
CAS:486459-88-5
SGT52B :
Sitagliptin 2-Desfluoro Impurity ;

(R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-phenylbutan-2-amine ;
SGT53B :
Sitagliptin Desfluorobenzene Analog ;

(R)-5,7-Difluorochroman-4-ol ;
CAS:1270294-05-7
TGP62 :
Tegoprazan RC 2 ;

(R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one ;
CAS:17654-19-2
NGX50 :
Naringenin (R)-Isomer ;

(R)-5-(2,2-Dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one ;
CAS:452339-73-0
VLT52 :
Vilanterol RC 2 ;

(R)-5-(2-((2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide ;
SLD53 :
Silodosin Deshydroxypropyl Impurity ;

(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)(methyl)amino)propyl)-2-methoxybenzenesulfonamide ;
TMS51 :
Tamsulosin N-Methyl Impurity ;

(R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine ;
CAS:1223404-90-7
LTT52 :
Larotrectinib DFP-PNPP Impurity ;

(R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine ;
CAS:1223404-88-3
LTT54 :
Larotrectinib DFP-PPPA Impurity ;

(R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidine ;
CAS:1223404-89-4
LTT53 :
Larotrectinib DFP-PPP Impurity ;

(R)-5-(2-(2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethylamino)propyl)-1H-indole-7-carboxamide ;
SLD63 :
Silodosin 1,2-Dehydro Dehydroxypropyl ;

(R)-5-(2-(Benzyl(2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide ;
CAS:1027854-97-2
TMS66 :
Tamsulosin RC 6 ; N- Benzyl Tamsulosin ;

(R)-5-(2-(Bis(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-1-(3-hydroxypropyl)indoline-7-carbonitrile ;
CAS:1453221-47-0
SLD83 :
Silodosin RC 13 ;

(R)-5-(2-Aminopropyl)-1-(3-hydroxypropyl)indoline-7-carbonitrile ;
CAS:1401991-17-0
SLD87 :
Silodosin RC 17 ;

(R)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalen-1(2H)-one ;
CAS:47141-41-3
LBN64B :
Levobunolol RC 4 (Base) ;

(R)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalen-1(2H)-one hydrochloride ;
CAS:27867-05-6
LBN64H :
Levobunolol RC 4 (HCl) ; R-Bunolol HCl ;

(R)-5-(Chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one ;
CAS:496031-57-3
LNZ67 :
Linezolid RC 7 ; Linezolid Impurity B ;

(R)-5-(Oxiran-2-ylmethoxy)-3,4-dihydronaphthalen-1(2H)-one ;
LBN65 :
Levobunolol RC 5 ;

(R)-5-[(1-Methylindol-3-yl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole ;
CAS:132036-88-5
RMS00B :
Ramosetron (Base) ;

(R)-5-[(1-Methylindol-3-yl)carbonyl]-4,5,6,7-tetrahydrobenzimidazole HCl ;
CAS:132907-72-3
RMS00H :
Ramosetron (HCl) ;

(R)-6-((R)-(2-Ethoxyphenoxy)(phenyl)methyl)morpholin-3-one ;
CAS:98769-79-0
RBX63 :
Reboxetine RC 3 ;

(R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide ;
FTT57 :
Frovatriptan N6-Methyl Impurity ; Frovatriptan Impurity 7 ;

(R)-6-(Methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide butanedioic acid monohydrate ;
CAS:158930-17-7
FTT00S :
Frovatriptan Succinate Monohydrate ;

(R)-6-(Methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxylic acid hydrochloride ;
FTT59H :
Frovatriptan Carboxylic Acid ; Frovatriptan Impurity 9 ;

(R)-6-Amino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide ;
CAS:146993-12-6
FTT21 :
Frovatriptan USP RC A ; N-Desmethyl Frovatriptan ;

(R)-6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid ;
CAS:138382-95-3
UFX41 :
Ulifloxacin (R)-Isomer ;

(R)-6-Fluoro-2-[(R)-oxiran-2-yl]chroman ;
NBV23R :
Nebivolol USP RC C (RR)-Isomer ;

(R)-6-Fluoro-2-[(S)-oxiran-2-yl]chroman ;
NBV24R :
Nebivolol USP RC D (RS)-Isomer ;

(R)-7-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-5-carboxamide ;
CAS:942195-56-4
TGP50 :
Tegoprazan R-Isomer ;

(R)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide ;
CAS:1691249-44-1
ZNB50 :
Zanubrutinib (R)-Isomer ;

(R)-7-(3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one ;
SGT60 :
Sitagliptin Oxo Impurity ;

(R)-7-Bromo-6-chloro-3-(2-oxo-3-(piperidin-2-yl)propyl)quinazolin-4(3H)-one ;
CAS:1819989-17-7
HLF67B :
Halofuginone RC 7 (Base) ;

(R)-7-Bromo-6-chloro-3-(2-oxo-3-(piperidin-2-yl)propyl)quinazolin-4(3H)-one dihydrobromide ;
CAS:1819989-18-8
HLF67X :
Halofuginone RC 7 (2HBr) ;

(R)-8-(1-Acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one ;
CAS:1917333-91-5
IBT72 :
Ibrutinib Impurity 22 ;

(R)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-enyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione ;
LGT82 :
Linagliptin RC 12 ; Linagliptin EP Impurity D (Z/E)-Mixture ;

(R)-8-(Benzyloxy)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)quinolin-2(1H)-one ;
CAS:435273-75-9
IDC62B :
Indacaterol RC 2 ;

(R)-9-(2-Phosphonomethoxypropyl)adenine ;
CAS:147127-20-6
TNF41B :
Tenofovir (Base) ; (R)-Tenofovir ; Tenofovir Disoproxil IP Impurity N ;

(R)-9-(Triisopropylsilyloxy)-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one ;
CAS:1190363-45-1
RMG63 :
Rimegepant RC 3 ;

(R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline ;
CAS:1255644-71-3
ITC12B :
Irinotecan EP Impurity L (Base) ; Irinotecan USP RC D ; Irinotecan R-Isomer ; Irinotecan Enantiomer ;

(R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride ;
CAS:1992961-26-8
ITC12H :
Irinotecan EP Impurity L (HCl) ; Irinotecan USP RC D ; Irinotecan HCl R-Isomer ; Irinotecan HCl Enantiomer ;

(R)-9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid ;
CAS:160961-35-3
NDF50 :
Nadifloxacin (R)-Isomer ;

(R)-9-Hydroxy-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one ;
CAS:1190363-44-0
RMG62 :
Rimegepant RC 2 ;

(R)-Benzhydryl 2-((R)-2-(2-(benzo[d]thiazol-2-yl)disulfanyl)-4-oxoazetidin-1-yl)-3-methylbut-3-enoate ;
CAS:87579-79-1
TZB61 :
Tazobactam RC 1 ;

(R)-Benzyl 1-(7-carbamoyl-1-(3-hydroxypropyl)indolin-5-yl)propan-2-yl(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)carbamate ;
SLD68 :
Silodosin N-Benzyloxycarbonyl Impurity ;

(R)-Benzyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate ;
CAS:196601-68-0
LSM63 :
Lacosamide Impurity 3 ;

(R)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride ;
CAS:2049127-88-8
LGS81H :
Lifitegrast RC 21 (HCl) ;

(R)-Diethyl (1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonate ;
CAS:180587-75-1
TNF54B :
Tenofovir Diethyl Ester (R)-Isomer ;

(R)-Diphenyl (1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonate ;
CAS:342631-41-8
TNF96 :
Tenofovir RC 6 ; Biphenyl PMPA ;

(R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate ;
CAS:145821-58-5
TGB21B :
Tiagabine USP RC A ; Tiagabine Ethyl Ester ;

(R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate hydrochloride ;
CAS:145821-60-9
TGB21H :
Tiagabine USP RC A (HCl) ; Tiagabine HCl Ethyl Ester ;

(R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate ;
CAS:149709-59-1
SCT72 :
Sacubitril RC 2 ;

(R)-Ethyl 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate ;
LFX75 :
Levofloxacin Impurity 15 ;

(R)-Isopropyl 9-(2-(((bis(benzyloxy))phosphoryl)methoxy)propyl)-9H-purin-6-ylcarbamate ;
CAS:1391052-09-7
TNF92 :
Tenofovir RC 2 ; Tenofovir Dibenzyloxy Isopropyl Carbamate ;

(R)-Methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)(nitroso)amino)-3-methylbutanoate ;
SCT85B :
Sacubitril RC 15 (Base) ;

(R)-Methyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)(nitroso)amino)-3-methylbutanoate oxalate ;
SCT85X :
Sacubitril RC 15 (Oxalate) ;

(R)-Methyl 2-(benzyloxy)propanoate ;
CAS:115458-99-6
LFX82 :
Levofloxacin Impurity 22 ;

(R)-Methyl 2-(benzyloxycarbonyl)-3-methoxypropanoate ;
CAS:209804-17-1
LSM65 :
Lacosamide Impurity 5 ;

(R)-Methyl 3-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoate ;
CAS:118316-16-8
UDC60 :
Ursodeoxycholic Acid RC 10 ;

(R)-Methyl 3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate ; Methyl 3-[(2R)-2,4-dihydroxy-3,3-dimethylbutanamido]propanoate ;
CAS:50692-78-9
PTT04 :
Pantothenate EP Impurity D ; Methyl Pantothenate ;

(R)-Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate ;
CAS:881995-69-3
SGT66B :
Sitagliptin Impurity 6 (Base) ; Sitagliptin Acid Methyl Ester ; Sitagliptin STA Impurity H ;

(R)-Methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate HCl ;
CAS:1374985-05-3
SGT66H :
Sitagliptin Impurity 6 (HCl) ; Sitagliptin Acid Methyl Ester HCl ; Sitagliptin STA Impurity H (HCl) ;

(R)-Methyl 4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
CAS:1249-75-8
LCX70 :
Lithocholic Acid RC 10 ; Methyl Lithocholate ;

(R)-Methyl 4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ; Methyl 3+¦,7-dihydroxy-6-ethyl-5+¦-cholanate ; 6-Ethyl-3,7-dihydroxy methyl ester cholan-24-oi
CAS:951694-73-8
OBT57 :
Obeticholic Acid Methyl Ester ;

(R)-Methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
CAS:10538-59-7
LCX72 :
Lithocholic Acid RC 12 ; Nutriacholic Acid Methyl Ester ;

(R)-Methyl 4-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-diacetoxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
CAS:60384-30-7
UDC52 :
Ursodeoxycholic Acid RC 2 ;

(R)-Methyl 4-((3R,7S,8R,9S,10S,13R,14S,17R)-7-acetoxy-3-hydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
CAS:75672-24-1
UDC51 :
Ursodeoxycholic Acid RC 1 ; 7-O-Acetyl Ursodeoxycholic Acid Methyl Ester ;

(R)-Methyl 4-((5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
CAS:1173-32-6
LCX71 :
Lithocholic Acid RC 11 ;

(R)-N-(1-(1-Acryloylpiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)acrylamide ;
IBT52 :
Ibrutinib Impurity 2 ;

(R)-N-(1-(2,6-Dimethylphenoxy)propan-2-yl)acetamide ;
CAS:141552-89-8
MLT66 :
Mexiletine RC 6 ;

(R)-N-(1-Phenylethyl)methanesulfonamide ;
CAS:316363-65-2
LRS62 :
Lurasidone Impurity 2 ;

(R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine ;
CAS:56862-28-3
SLG04B :
Selegiline EP Impurity D (Base) ; Selegiline USP RC D ; N-Desmethyl Selegiline ;

(R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride ;
CAS:115586-38-4
SLG04H :
Selegiline EP Impurity D (HCl) ; Selegiline USP RC D (HCl) ; N-Desmethyl Selegiline HCl ;

(R)-N-(2-(2,8-Dihydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide ;
RMT72 :
Ramelteon RC 2 ;

(R)-N-(2-Acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-2,6-dioxo-2,3-dihydro-6H-purin-1(7H)-yl)acetamide ;
CAS:2416949-69-2
LGT12 :
Linagliptin EP Impurity L ; Linagliptin USP RC B ; Linagliptin RC 7 ;

(R)-N-(2-Chloroallyl)-2,3-dihydro-1H-inden-1-amine ;
CAS:1175018-73-1
RSG62B :
Rasagiline RC 2 (Base) ; Rasagiline Vinylchloride Analog (Base) ;

(R)-N-(2-Chloroallyl)-2,3-dihydro-1H-inden-1-amine HCl ;
CAS:1175018-75-3
RSG62H :
Rasagiline RC 2 (HCl) ; Rasagiline Vinylchloride Analog (USP) ;

(R)-N-(2-Chloroallyl)-2,3-dihydro-1H-inden-1-amine oxalate ;
RSG62X :
Rasagiline RC 2 (Oxalate) ; Rasagiline Vinylchloride Analog (Oxalate) ;

(R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine ;
CAS:1094089-46-9
PNP27A :
Phenylephrine USP RC G (Acid) ;

(R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine sodium salt ;
PNP27N :
Phenylephrine USP RC G (Na) ;

(R)-N-(4-(((2R,5S)-5-((S)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide ;
VBG50 :
Vibegron Enantiomer ;

(R)-N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide ;
CAS:2376909-00-9
TVT73 :
Tolvaptan RC 3 ;

(R)-N-(4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide ;
SGT54 :
Sitagliptin N-Formyl Impurity ;

(R)-N-(Quinuclidin-3-yl)-5,6,7,8-tetrahydronaphthalene-1-carboxamide ;
CAS:135729-78-1
PLN61 :
Palonosetron RC 1 ;

(R)-N-(Quinuclidin-3-yl)-5,6-dihydronaphthalene-1-carboxamide ;
CAS:1227162-75-5
PLN62 :
Palonosetron RC 2 ;

(R)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl] methyl] phthalimide ;
CAS:947736-16-5
LNZ75 :
Linezolid RC 15 ; Linezolid Desacetamide Phthalimide (R)-Isomer ;

(R)-N-Benzyl-2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetamide ;
CAS:1150310-68-1
LCZ61B :
Levocetirizine N-Benzylamide ;

(R)-N-Benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine ;
CAS:71799-91-2
PBZ61B :
Phenoxybenzamine (R)-Isomer ;

(R)-N-Benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine hydrochloride ;
CAS:16053-59-1
PBZ61H :
Phenoxybenzamine (R)-Isomer (HCl) ;

(R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride ;
CAS:14611-52-0
SLG00H :
Selegiline Hydrochloride ;

(R)-N-Nitroso-N-((S)-1-phenylethyl)quinuclidin-3-amine ;
PLN66 :
Palonosetron RC 6 ;

(R)-N-Nitroso-N-(prop-2-ynyl)-2,3-dihydro-1H-inden-1-amine ;
CAS:2470278-90-9
RSG48 :
Rasagiline N-Nitroso Impurity ;

(R)-N-tert-Butyl-2,3-bis(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-amine ;
CAS:1391068-05-5
TML57 :
Timolol Impurity 7 ;

(R)-N-Valeryl-N-([2'-(1H-tetrazole-5-yl)biphen-4-yl]methyl)valine ;
CAS:137862-87-4
VST21 :
Valsartan USP RC A ; Valsartan EP Impurity A ; Valsartan (R)-Isomer ;

(R)-N-Valeryl-N-([2'-(2-trityl-tetrazol-5-yl)biphenyl-4-yl]methyl)valine ;
VST44 :
Valsartan N2-Trityl (R)-Isomer ;

(R)-Pyrrolidine-2-carboxamide ;
CAS:62937-45-5
VDG82 :
Vildagliptin Impurity 12 ; D-Prolinamide ;

(R)-Quinuclidin-3-yl 2-benzoylphenethylcarbamate ;
CAS:1956436-64-8
SLF21B :
Solifenacin USP RC A ; (R)-Quinuclidinyl Benzoyl Solifenacin ;

(R)-Quinuclidin-3-yl carbonochloridate ;
CAS:201660-37-9
SLF71B :
Solifenacin Impurity 11 ;

(R)-sec-Butyl 4-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
UDC42 :
Ursodeoxycholic Acid 2-Butyl Ester ;

(R)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-(benzyloxy)propan-2-yl)carbamate ;
CAS:1932671-22-1
SCT69 :
Sacubitril AHU-78 ;

(R)-tert-Butyl 1-(2,5-difluorophenyl)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-2-ylcarbamate ;
CAS:486460-22-4
SGT68 :
Sitagliptin Impurity 8 ;

(R)-tert-Butyl 1-(7-carbamoyl-1-(3-hydroxypropyl)indolin-5-yl)propan-2-yl(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)carbamate ;
CAS:160970-07-0
SLD69 :
Silodosin N-t-BOC Impurity ;

(R)-tert-Butyl 1-benzylpiperidin-3-ylcarbamate ;
CAS:454713-13-4
LGT80 :
Linagliptin RC 10 ;

(R)-tert-Butyl 2-((R)-hydroxy(phenyl)methyl)morpholine-4-carboxylate ;
CAS:1030837-58-1
RBX68 :
Reboxetine RC 8 ;

(R)-tert-Butyl 2-((S)-(methylsulfonyloxy)(phenyl)methyl)morpholine-4-carboxylate ;
CAS:1030837-66-1
RBX73 :
Reboxetine RC 13 ;

(R)-tert-Butyl 2-benzoylmorpholine-4-carboxylate ;
CAS:869088-60-8
RBX61 :
Reboxetine RC 1 ;

(R)-TERT-BUTYL 3-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE
CAS:1022150-11-3
IBT42 :
Ibrutinib N-BOC Analog ; N-BOC-Ibrutinib ;

(R)-tert-Butyl 3-aminopiperidine-1-carboxylate ;
CAS:188111-79-7
LGT73 :
Linagliptin RC 3 ;

(R)-tert-Butyl 4-aminophenethyl(2-hydroxy-2-phenylethyl)carbamate ;
CAS:223673-36-7
MRB41B :
Mirabegron RC 1 ;

(R)-tert-Butyl 4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-ylcarbamate ;
CAS:486460-23-5
SGT58 :
Sitagliptin N-BOC Amide ;

(R)-tert-Butyl 6-chloro-5-hydroxy-3-oxohexanoate ;
CAS:404958-08-3
RSVA5 :
Rosuvastatin Impurity 5 ;

(R*,R*)-5,5GÇÖ-Bis(+¦-D-glucopyranosyloxy)-9,9GÇÖ,10,10GÇÖ-tetrahydro-4,4GÇÖ-dihydroxy-10,10GÇÖ-dioxo[9,9GÇÖ-Bianthracene]-2,2GÇÖ-dicarboxylic acid ;
CAS:81-27-6
SNS51 :
Sennoside A ;

(R*,S*)-5,5GÇÖ-Bis(+¦-D-glucopyranosyloxy)-9,9GÇÖ,10,10GÇÖ-tetrahydro-4,4GÇÖ-dihydroxy-10,10GÇÖ-dioxo-[9,9GÇÖ-Bianthracene]-2,2GÇÖ-dicarboxylic acid ;
CAS:128-57-4
SNS52 :
Sennoside B ;

(R,E)-2-(1-((1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(4-hydroxy-2-(2-hydroxypropan-2-yl)phenyl)propylthio)methyl)cyclopropyl)acetic acid ;
CAS:200804-28-0
MTL90 :
Montelukast Impurity 10 ;

(R,E)-2-(3-(2-(Carboxymethyl)-3,4-dihydroxyphenyl)acryloyloxy)-3-(3,4-dihydroxyphenyl)propanoic acid ;
CAS:142998-47-8
SVN04
Salvianolic Acid D ;

(R,E)-2-(4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile ;
CAS:187164-19-8
LZL00 :
Luliconazole ; Luliconazole (R,E)-Isomer ;

(R,E)-2-(4-(4-Chlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile ;
CAS:187164-18-7
LZL60 :
Luliconazole 2-Deschloro (R,E)-Isomer ;

(R,E)-3-(3,4-Dihydroxyphenyl)-2-(3-(2-(3,5-dihydroxyphenyl)-4-hydroxybenzofuran-7-yl)acryloyloxy)propanoic acid ;
CAS:115841-09-3
SVN03
Salvianolic Acid C ;

(R,E)-3-(Hexadec-2-enoyloxy)-4-(trimethylammonio)butanoate ;
CAS:26145-55-1
LCT69 :
Levocarnitine RC 9 ; trans-2-Hexadecenoyl L-Carnitine ;

(R,E)-4-((1-([1,1'-Biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopent-3-en-2-yl)amino)-4-oxobutanoic acid ;
CAS:2957885-24-2
SCTA1 :
Sacubitril RC 31 ; Sacubitril Dehydrogenated ;

(R,E)-4-(1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propylthio)-3,3-dimethylbutanoic acid ;
CAS:162489-70-5
MTL91 :
Montelukast Impurity 11 ;

(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid ;
CAS:1012341-48-8
SCTA2A :
Sacubitril RC 32 (Acid) ;

(R,E)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-enyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione ;
CAS:1446263-39-3
LGT83 :
Linagliptin RC 13 ; Linagliptin EP Impurity D trans-Isomer ;

(R,E)-Methyl 2-(3-(acetylthio)-3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)propyl)benzoate ;
CAS:855473-48-2
MTL83 :
Montelukast Impurity 3 ;

(R,Z)-2-(4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile ;
CAS:1240249-76-6
LZL52 :
Luliconazole (R,Z)-Isomer ;

(R,Z)-2-(4-(4-Chlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile ;
LZL62 :
Luliconazole 2-Deschloro (R,Z)-Isomer ;

(R,Z)-3-(Oleoyloxy)-4-(trimethylammonio)butanoate ;
CAS:38677-66-6
LCT50 :
Levocarnitine Oleoyl ; Oleoyl L-Carnitine ;

(R,Z)-3-(Tetradec-5-enoyloxy)-4-(trimethylammonio)butanoate ;
CAS:1186416-86-3
LCT71 :
Levocarnitine RC 11 ; 5-cis-Tetradecenoyl L-Carnitine ;

(R,Z)-7-((1S,2S,6R,8S)-2,6-Dimethyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-5-hydroxyhept-2-enoic acid ;
CAS:1649503-10-5
LVS63A :
Lovastatin Impurity 3 (Acid) ;

(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-enyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione ;
CAS:1638744-06-5
LGT04 :
Linagliptin EP Impurity D ; Linagliptin USP RC D ; Linagliptin RC 14 ;

(R,Z)-Methyl 2-(3-(4-(methylsulfinyl)benzylidene)-6-fluoro-2-methyl-3H-inden-1-yl)acetate ;
CAS:929081-61-8
SDC52 :
Sulindac (R)-Isomer Methyl Ester ;

(R,Z)-N-((S)-4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-ylidene)-2-methylpropane-2-sulfinamide ;
CAS:674767-90-9
STL52 :
Sertraline 2-Methylpropane 2-Sulfinamide ;

(RS)-(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanol ;
CAS:29606-06-2
TMM03B :
Trimethoprim EP Impurity C (Base) ; +¦-Hydroxy Trimethoprim ;

(RS)-(2,4-Diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanol HCl ;
TMM03H :
Trimethoprim EP Impurity C (HCl) ; +¦-Hydroxy Trimethoprim HCl ;

(RS)-(2-Fluorophenyl)(4-fluorophenyl)methoxyphenylmethane ;
FTZ03 :
Flutrimazole EP Impurity C ;

(RS)-(2-Fluorophenyl)(4-fluorophenyl)phenylmethanol ;
CAS:128092-72-8
FTZ02 :
Flutrimazole EP Impurity B ;

(RS)-(2-Methylphenyl)phenylmethanol ;
CAS:5472-13-9
OPD01 :
Orphenadrine EP Impurity A ; 2-Methylbenzhydrol ;

(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl](pyridin-2-yl)methanol ;
CAS:68496-04-8
MFQ02B :
Mefloquine EP Impurity B ; Dehydro Mefloquine ;

(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2RS)-piperidin-2-yl]methanol ;
CAS:49752-90-1
MFQ03B :
Mefloquine EP Impurity C (Base) ; Mefloquine USP RC A ; threo-Mefloquine ;

(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2RS)-piperidin-2-yl]methanol HCl ;
MFQ03H :
Mefloquine EP Impurity C (HCl) ; Mefloquine USP RC A ; threo-Mefloquine HCl ;

(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2SR)-piperidin-2-yl]methanol ;
CAS:53230-10-7
MFQ00B :
Mefloquine (Base) ; (R,S)-Mefloquine & Enantiomer ;

(RS)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2SR)-piperidin-2-yl]methanol hydrochloride ;
CAS:51773-92-3
MFQ00H :
Mefloquine (HCl) ; Mefloquine Hydrochloride ; (R,S)-Mefloquine HCl & Enantiomer ;

(RS)-1-(tert-Butylamino)-3-(2-cyclopentenylphenoxy)propan-2-ol ;
CAS:121010-10-4
PBT51B :
Penbutolol EP Impurity A Racemate ;

(RS)-1-[(2-Fluorophenyl)(4-fluorophenyl)phenylmethyl]-1H-imidazole ;
CAS:119006-77-8
FTZ00 :
Flutrimazole ;

(RS)-1-[(4-Chlorophenyl)phenylmethyl]-piperazine ;
CAS:303-26-4
HDZ01 :
Hydroxyzine EP Impurity A ; Cetirizine EP Impurity A ; Hydroxyzine BP Impurity A ; Hydroxyzine USP RC A ; N-Desalkyl Hydroxyzine ; Levocetirizine EP Impurity I ;

(RS)-1-[2-[(7-Chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole ;
CAS:99592-32-2
SCZ00B :
Sertaconazole ;

(RS)-1-[2-[(7-Chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate ;
CAS:99592-39-9
SCZ00N :
Sertaconazole Nitrate ;

(RS)-10-Fluoro-2,3-dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ;
CAS:197291-75-1
OFX04B :
Ofloxacin EP Impurity D (base) ; Ofloxacin 10-Fluoro Isomer ; Ofloxacin 9-Piperazinyl Analog ;

(RS)-10-Fluoro-2,3-dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ethyl ester ;
CAS:2172959-66-7
OFX34 :
Ofloxacin EP Impurity D Ethyl Ester ;

(RS)-10-Fluoro-2,3-dihydro-3-methyl-9-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid HCl ;
OFX04H :
Ofloxacin EP Impurity D (HCl) ; Ofloxacin HCl 10-Fluoro Isomer ; Ofloxacin HCl 9-Piperazinyl Analog ;

(RS)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ;
CAS:95848-94-5
OFX03 :
Ofloxacin EP Impurity C ; Ofloxacin Desfluoro Impurity ;

(RS)-2-(2-Oxopyrrolidin-1-yl)butanamide ;
CAS:33996-58-6
LET30 :
Levetiracetam Racemate ;

(RS)-2-(Ethylamino)-N-(2-methylphenyl)propanamide ;
CAS:42459-37-0
PLC03B :
Prilocaine EP Impurity C (Base) ;

(RS)-2-(Ethylamino)-N-(2-methylphenyl)propanamide hydrochloride ;
CAS:35891-75-9
PLC03H :
Prilocaine EP Impurity C (HCl) ;

(RS)-2-[(2-Methylphenyl)phenylmethoxy]ethanamine ;
CAS:17349-96-1
OPD03B :
Orphenadrine EP Impurity C (Base) ; N,N-Didemethyl Orphenadrine ;

(RS)-2-[(2-Methylphenyl)phenylmethoxy]ethanamine hydrochloride ;
CAS:17752-32-8
OPD03H :
Orphenadrine EP Impurity C (HCl) ; N,N-Didemethyl Orphenadrine HCl ;

(RS)-2-[2-[4-[(2-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy] acetic acid dihydrochloride ;
CAS:2702511-37-1
LCZ06H :
Levocetirizine EP Impurity F (2HCl) ; Cetirizine EP Impurity C (2HCl) ; 2-Chloro Cetirizine Dihydrochloride (USP) ;

(RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethanol dihydrochloride ;
CAS:2192-20-3
HDZ00H :
Hydroxyzine Dihydrochloride ;

(RS)-2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]acetic acid ;
LCZ06B :
Levocetirizine EP Impurity F (Base) ;

(RS)-2-Amino-4,5,6,7-tetrahydro-6-acetylaminobenzothiazole ;
PMP66B :
Pramipexole N6-Acetyl Racemate ;

(RS)-2-Amino-4,5,6,7-tetrahydro-6-aminobenzothiazole ;
CAS:104617-49-4 106006-83-1
PMP56B :
Pramipexole N6-Despropyl Racemate ;

(RS)-2-Amino-5,6-dihydro-6-(propylamino)-7(4H)-benzothiazolone ;
CAS:1286047-33-3
PMP31B :
Pramipexole 7-Oxo Racemate (Base) ;

(RS)-2-Amino-5,6-dihydro-6-(propylamino)-7(4H)-benzothiazolone dihydrochloride ;
CAS:1432061-98-7
PMP31D :
Pramipexole 7-Oxo Racemate (2HCl) ;

(RS)-2-Amino-5,6-dihydro-6-(propylamino)-7(4H)-benzothiazolone trihydrochloride ;
PMP31T :
Pramipexole 7-Oxo Racemate (3HCl) ;

(RS)-2-Chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-Oxide ;
CAS:40722-73-4
IFF06 :
Ifosfamide EP Impurity F ;

(RS)-2-Chloro-N-(2-methylphenyl)propanamide ;
CAS:19281-31-3
PLC01 :
Prilocaine EP Impurity A ;

(RS)-2-Cyclohexyl-2-hydroxy-2-phenylacetic acid ; Phenylcyclohexylglycolic acid ;
CAS:4335-77-7
OXB04 :
Oxybutynin EP Impurity D ; Oxybutynin USP RC A ;

(RS)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol ;
CAS:17692-31-8
LDZ51B :
Levodropropizine Racemate ; Dropropizine ;

(RS)-3-(Carbamoylmethyl)-5-methylhexanoic acid ;
CAS:181289-15-6
PRG08 :
Pregabalin EP Impurity H ; Pregabalin 3-Carbamoylmethyl Racemate ;

(RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium ;
CAS:1404617-94-2
GPB09B :
Glycopyrrolate EP Impurity I (Base) ; Glycopyrrolate USP RC I ;

(RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide ;
CAS:1404453-68-4
GPB09X :
Glycopyrrolate EP Impurity I (Bromide) ; Glycopyrrolate USP RC I ;

(RS)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol ;
CAS:2947-04-08 00:00:00
NRD54B :
Noradrenaline Methyl Ether Racemate (Base) ;

(RS)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol hydrochloride ;
CAS:3770-01-02 00:00:00
NRD54H :
Noradrenaline Methyl Ether Racemate (HCl) ;

(RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid ;
CAS:330838-52-3
TNX03B :
Tranexamic Acid EP Impurity C (Base) ; Tranexamic Acid USP RC C ; Dehydro Tranexamic Acid ;

(RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid HCl ;
CAS:1803601-44-6
TNX03H :
Tranexamic Acid EP Impurity C (HCl) ; Tranexamic Acid USP RC C ; Dehydro Tranexamic Acid HCl ;

(RS)-5-(4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl)thiazolidine-2,4-dione hydrochloride ;
CAS:112529-15-4
PGT00H :
Pioglitazone HCl ;

(RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman ; Mixture of (R)-6-Fluoro-2-[(R)-oxiran-2-yl]chroman and its enantiomer ;
CAS:876514-31-7
NBV23M :
Nebivolol USP RC C ;

(RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman ; Mixture of (R)-6-Fluoro-2-[(S)-oxiran-2-yl]chroman and its enantiomer ;
CAS:793669-26-8
NBV24M :
Nebivolol USP RC D ;

(RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydro-furan-5-yl)-ethyl]-3H-isobenzofuranyl-1-one ;
CAS:26675-76-3
MCP08 :
Mycophenolate Mofetil EP Impurity H ; Mycophenolate Mofetil USP RC B ; Mycophenolate Sodium EP Impurity A ; Mycophenolic Acid Lactone ;

(RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-hydroxy-2-(5-methyl-2-oxo-tetrahydro-furan-5-yl)-ethyl]-3H-isobenzofuranyl-1-one ;
CAS:26644-06-4
MCP35 :
Mycophenolic Hydroxy Lactone ;

(RS)-9,10-Difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid (FPA) ;
CAS:82419-35-0
OFX01 :
Ofloxacin EP Impurity A ; Ofloxacin Difluoro Carboxylic Acid ;

(RS)-9-Fluoro-10-[formyl[2-(formylmethylamino)ethyl]amino]-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ; N,NGÇÖ-Desethylene-N,NGÇÖ-diformyl Ofloxacin ;
OFX36 :
Ofloxacin Desethylene Diformyl Impurity ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ;
CAS:82419-52-1
OFX05B :
Ofloxacin EP Impurity E (Base) ; Ofloxacin USP RC A ; N-Desmethyl Ofloxacin ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid HCl ;
CAS:402930-70-5
OFX05H :
Ofloxacin EP Impurity E (HCl) ; Ofloxacin USP RC A ; N-Desmethyl Ofloxacin HCl ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine ;
CAS:123155-82-8
OFX02 :
Ofloxacin EP Impurity B ; Ofloxacin Descarboxyl Impurity ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ;
CAS:82419-36-1
OFX00 :
Ofloxacin ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid N-oxide ;
CAS:104721-52-0
OFX06B :
Ofloxacin EP Impurity F ; Ofloxacin N-Oxide ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid N-oxide acetate salt ;
CAS:1216511-73-7
OFX06A :
Ofloxacin EP Impurity F (Acetate) ; Ofloxacin N-Oxide Acetate Salt ;

(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-[(2-methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine hydrochloride ;
CAS:1797983-25-5
OFX35H :
Ofloxacin Desethylene Impurity ; N,NGÇÖ-Desethylene Ofloxacin Hydrochloride ;

(RS)-N,3-Bis(2-Chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide ;
CAS:3778-73-2
IFF00 :
Ifosfamide ;

(RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]-ethanamine ;
CAS:83-98-7
OPD00B :
Orphenadrine (Base) ;

(RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]-ethanamine citrate salt ;
CAS:4682-36-4
OPD00C :
Orphenadrine Citrate ;

(RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]-ethanamine hydrochloride ;
CAS:341-69-5
OPD00H :
Orphenadrine (HCl) ;

(RS)-N,N-Dimethyl-2-[(3-methylphenyl)phenylmethoxy]-ethanamine ;
CAS:21945-86-8
OPD05B :
Orphenadrine EP Impurity E ; Orphenadrine USP RC E ; Orphenadrine meta-Methyl Analog ;

(RS)-N,N-Dimethyl-2-[(4-methylphenyl)phenylmethoxy]-ethanamine ;
CAS:19804-27-4
OPD06B :
Orphenadrine EP Impurity F (Base) ; Orphenadrine USP RC F ; Orphenadrine para-Methyl Analog ; Diphenhydramine EP Impurity B ;

(RS)-N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride ;
CAS:1722-62-9
MVC00H :
Mepivacaine HCl ; Ropivacaine EP Impurity C Racemate ; N-Methyl Ropivacaine HCl Racemate ;

(RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide ;
CAS:15883-20-2
MVC02B :
Mepivacaine EP Impurity B (Base) ; Bupivacaine EP Impurity B ; Bupivacaine USP RC B ; N-Desbutyl Bupivacaine ;

(RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide HCl ;
CAS:65797-42-4
MVC02H :
Mepivacaine EP Impurity B (HCl) ; Bupivacaine EP Impurity B ; Bupivacaine USP RC B ; N-Desbutyl Bupivacaine HCl ;

(RS)-N-(2-Methylphenyl)-2-(propylamino)propanamide ;
CAS:721-50-6
PLC00B :
Prilocaine (Base) ;

(RS)-N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride ;
CAS:1786-81-8
PLC00H :
Prilocaine (HCl) ;

(RS)-N-(3-Methylphenyl)-2-(propylamino)propanamide ;
CAS:875252-65-6
PLC04B :
Prilocaine EP Impurity D (Base) ;

(RS)-N-(3-Methylphenyl)-2-(propylamino)propanamide HCl ;
CAS:878791-35-6
PLC04H :
Prilocaine EP Impurity D (HCl) ;

(RS)-N-(4-Chloro-2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide ;
MVC05 :
Mepivacaine EP Impurity E ;

(RS)-N-(4-Methylphenyl)-2-(propylamino)propanamide ;
CAS:744961-76-0
PLC05B :
Prilocaine EP Impurity E (Base) ; Prilocaine USP RC B ; 2-Desmethyl 4-Methyl Prilocaine ;

(RS)-N-(4-Methylphenyl)-2-(propylamino)propanamide HCl ;
CAS:35891-99-7
PLC05H :
Prilocaine EP Impurity E (HCl) ; Prilocaine USP RC B ; 2-Desmethyl 4-Methyl Prilocaine HCl ;

(RS)-N-Phenyl-2-(propylamino)propanamide ;
CAS:42459-45-0
PLC06B :
Prilocaine EP Impurity F ;

(S)-((1E,3S,4R,5S,8R,9E,12S,14S)-8-Allyl-5-hydroxy-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-14-methoxy-14-((2R,3S,5R)-3-methoxy-5-methyl-6-oxo-tetrahydro-2H-pyran-2-yl)-2,4,10,12-tetramethyl-7-oxotetradeca-1,9-dien-3-yl) 1-formylpiperid
TCL08 :
Tacrolimus EP Impurity H ; Tacrolimus N-Formyl Impurity ;

(S)-((1S,7S,8S)-8-(2-((2R,4R)-4-Hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-3-methylene-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate ;
CAS:121624-17-7
LVS62 :
Lovastatin Impurity 2 ;

(S)-((2R,3S,4R,5R)-5-(4-Aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydrofuran-2-yl)methyl phenyl phosphoramidate ;
RDV52 :
Remdesivir Desalanyl Impurity ;

(S)-((2S,3S)-5-amino-1,6-diphenyl-2-((thiazol-5-ylmethoxy)carbonyl)hexan-3-yl) 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate ;
CAS:959315-21-0
RTN52B :
Ritonavir O-Acyl Isomer (Base) ;

(S)-((2S,3S)-5-amino-1,6-diphenyl-2-((thiazol-5-ylmethoxy)carbonyl)hexan-3-yl) 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate hydrochloride ;
RTN52H :
Ritonavir O-Acyl Isomer (HCl) ;

(S)-((7S,8S,10S)-7-(((R)-1-Phenylethyl)carbamoyl)-8-hydroxyhenicosan-10-yl) 2-formamido-4-methylpentanoate ;
OLS74 :
Orlistat Carbamoyl Impurity ; Orlistat Amide Impurity ;

(S)-((S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-(dimethylamino)-4-methylpentanoate ;
OLS73 :
Orlistat N-Desformyl N,N-Dimethyl Impurity ;

(S)-((S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 4-methyl-2-(methyl amino)pentanoate ;
OLS43 :
Orlistat N-Desformyl N-Methyl Impurity ;

(S)-((S,E)-Henicos-8-en-10-yl) 2-formamido-4-methylpentanoate ;
CAS:130676-63-0
OLS42 :
Orlistat Open-Ring Anhydro Decarboxy Impurity ; Orlistat Henicosenyl Leucinate Impurity ;

(S)-(+)-3-(Aminomethyl)-5-methylhexanoic acid methyl ester HCl ;
CAS:714230-22-5
PRG32H :
Pregabalin Methyl Ester (HCl) ;

(S)-(+)-3-(N-Methylaminomethyl)-5-methylhexanoic acid ;
CAS:1155843-61-0
PRG33 :
Pregabalin N-Methyl Impurity ;

(S)-(-)-1-[2-[(4-Chlorophenyl)-phenyl-methoxy]ethyl]piperidine hydrochloride ;
CAS:220282-83-7
LCP00B :
Levocloperastine D-Isomer (HCl) ; Dextrocloperatine HCl ;

(S)-(4,5-Dimethoxy-1,2-dihydrocyclobutabenzen-1-yl)-N-methylmethanamine ;
CAS:866783-12-2
IVB66B :
Ivabradine RC 6 (Base) ;

(S)-(4,5-Dimethoxy-1,2-dihydrocyclobutabenzen-1-yl)-N-methylmethanamine hydrochloride
CAS:866783-13-3
IVB66H :
Ivabradine RC 6 (HCl) ;

(S)-(4-Chlorophenyl)(phenyl)methanol ; (S)-4-Chlorobenzhydrol ;
CAS:101402-04-4
LCP56S :
Levocloperastine CBZ (S)-Isomer ;

(S)-(6-(Propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)carbamic acid ;
PMP50B :
Pramipexole N2-Formic Acid Impurity ; Pramipexole Carbamic Acid Impurity ;

(S)-(7,8-Difluoro-3-methyl-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)methanesulfonamide ;
LFX74 :
Levofloxacin Impurity 14 ;

(S)-[(2R,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol ;
CAS:56-54-2
QNN01B :
Quinine EP Impurity A ; Quinidine ;

(S)-[(2R,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]oct-2-yl](quinolin-4-yl)methanol ;
CAS:118-10-5
QND02 :
Quinidine EP Impurity B ; Cinchonine ;

(S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol ;
CAS:1435-55-8
QND03 :
Quinidine EP Impurity C ; Dihydroquinidine ; Hydroquinidine ;

(S)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol ;
MFQ53B :
Mefloquine (S,R)-Isomer (Base) ; (S,R)-Mefloquine ;

(S)-[2,8-Bis(trifluoromethyl)quinolin-4-yl][(2S)-piperidin-2-yl]methanol ;
CAS:51744-85-5
MFQ54B :
Mefloquine (S,S)-Isomer (Base) ; (S,S)-Mefloquine ; (+)-Threo-Mefloquine ;

(S)-1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine ;
CAS:61337-87-9
MTZ54 :
Mirtazapine (S)-Isomer ;

(S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid ;
CAS:74163-81-8
QPR01 :
Quinapril EP Impurity A ; Quinapril Bicyclic Acid ;

(S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid benzyl ester HCl ;
CAS:103733-30-8
QPR32 :
Quinapril Bicyclic Acid Benzyl Ester ;

(S)-1-((2R,3S)-5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenylsulfonyl)-3-hydroxyindoline-2-carbonyl)pyrrolidine-2-carboxamide ;
CAS:150375-75-0
RCV00 :
Relcovaptan ;

(S)-1-((S)-2-((S)-1-Carboxy-3-phenylpropylamino)-6-(carboxymethylamino)hexanoyl)pyrrolidine-2-carboxylic acid ammonium salt ;
CAS:92122-26-4
LSN50A :
Lisinopril N-Carboxymethyl (Acid) ;

(S)-1-((S)-2-((S)-1-Carboxy-3-phenylpropylamino)-6-(carboxymethylamino)hexanoyl)pyrrolidine-2-carboxylic acid ammonium salt ;
LSN50N :
Lisinopril N-Carboxymethyl (Ammonium Salt) ;

(S)-1-([1,1'-Biphenyl]-4-yl)-3-chloropropan-2-ol ;
CAS:1573000-28-8
SCT88 :
Sacubitril RC 18 ;

(S)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide ;
CAS:1152311-99-3
TZC70 :
Tezacaftor S-Isomer ; Tezacaftor Enantiomer ;

(S)-1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one ;
CAS:107381-32-8
PRP57 :
Propafenone (S)-Isomer ;

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide ;
CAS:214398-99-9
VDG54 :
Vildagliptin Chloroacetyl Amide (S)-Isomer ;

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxylic acid methyl ester ;
CAS:38074-72-5
VDG74 :
Vildagliptin Chloroacetyl Methyl Ester ; Vildagliptin Impurity I ;

(S)-1-(2-Hydroxyacetyl)pyrrolidine-2-carboxamide ;
CAS:96166-39-1
VDG60 :
Vildagliptin Hydroxyacetyl Amide (S)-Isomer ;

(S)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one ;
IBT67 :
Ibrutinib Impurity 17 ;

(S)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethanone ;
IBT69 :
Ibrutinib Impurity 19 ;

(S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride ;
CAS:1800020-46-5 (Base)
RVS25 :
Rivastigmine USP RC E ; N-Methyl Rivastigmine Chloride ;

(S)-1-(6-Amino-9H-purin-9-yl)propan-2-ol ;
CAS:14047-27-9
TNF61B :
Tenofovir (S)-Propanol Impurity ;

(S)-1-(Benzyloxy)-3-(biphenyl-4-yl)propan-2-ol ;
CAS:1932671-20-9
SCT65 :
Sacubitril AHU-73 ;

(S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile ;
CAS:207557-35-5
VDG53 :
Vildagliptin Chloroacetyl Nitrile (S)-Isomer ;

(S)-1-(tert-Butylamino)-3-(2-cyclopentenylphenoxy)propan-2-ol ;
CAS:112160-87-9
PBT01B :
Penbutolol EP Impurity A ;

(S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-[(2-hydroxyethyl)amino]-1,2,5-thiadiazol-3-yl]oxy]-2-propanol ;
CAS:75014-26-5
TML59 :
Timolol Impurity 9 ;

(S)-1-Acetamido-3-chloropropan-2-yl acetate ;
CAS:183905-31-9
LNZ64 :
Linezolid RC 4 ;

(S)-1-Azido-3-(N-(3-fluoro-4-morpholinophenyl)acetamido)propan-2-yl acetate ;
LNZ42 :
Linezolid N,O-Diacetyl Azido Impurity ;

(S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide ;
CAS:27262-47-1
RPV01B :
Ropivacaine EP Impurity A (Base) ; Levobupivacaine ; ( S)-Bupivacaine ; Ropivacaine N-Butyl Analog ;

(S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide HCl ;
CAS:27262-48-2
RPV01H :
Ropivacaine EP Impurity A (HCl) ; Levobupivacaine HCl ; ( S)-Bupivacaine HCl ; Ropivacaine HCl N-Butyl Analog ;

(S)-1-Chloro-3-((3-fluoro-4-morpholinophenyl)amino)propan-2-ol ;
CAS:1610690-08-8
LNZ43 :
Linezolid Chlorohydrin Impurity ;

(S)-1-Nitrosopyrrolidine-2-carboxylic acid ;
CAS:7519-36-0
VDG46 :
Vildagliptin N-Nitroso L-Proline ;

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline ;
CAS:118864-75-8
SLF01B :
Solifenacin EP Impurity A ; Solifenacin Phenyl Tetrahydroisoquinoline Impurity ; Solifenacin PTHI Impurity ;

(S)-1-Phenyl-3,4-dihydroisoquinoline-2(1H)-carbonyl chloride ;
CAS:1195949-26-8
SLF69 :
Solifenacin Impurity 9 ;

(S)-1-tert-Butyl 2-ethyl 5-oxopyrrolidine-1,2-dicarboxylate ;
CAS:144978-12-1
SXG71 :
Saxagliptin RC 11 ;

(S)-10-(1-Aminocyclopropyl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid ;
PZF56 :
Pazufloxacin Impurity 6 ; Desfluoro Pazufloxacin ;

(S)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-2,3-dihydro-[1,4]oxazino[2,3,4-ij]quinolin-7-one ;
CAS:777824-29-0
PZF55 :
Pazufloxacin Impurity 5 ;

(S)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid mesylate ;
CAS:163680-77-1
PZF00M :
Pazufloxacin Mesylate ; S-Pazufloxacin Mesylate ;

(S)-10-(1-Aminocyclopropyl)-9-fluoro-6-hydroxy-3-methyl-2,3-dihydro-[1,4]oxazino[2,3,4-ij]quinolin-7-one ;
CAS:171567-48-9
PZF62 :
Pazufloxacin Impurity 12 ; 6-Hydroxy Pazufloxacin ;

(S)-10-(1-Aminocyclopropyl)-9-hydroxy-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid ;
PZF58 :
Pazufloxacin Impurity 8 ; 9-Hydroxy Pazulfoxacin ;